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Summary  
Respiratory complex I (proton-pumping NADH:ubiquinone oxidoreductase) is a very large 
multiprotein complex found in most energy converting membranes of bacteria and eukaryotes. 
Composed of 14 subunits in bacteria, this complex is much larger in eukaryotes since it comprises more 
than 40 subunits in human and the green alga Chlamydomonas reinhardtii, which are encoded by both 
nuclear and mitochondrial genomes. It is well recognized that the assembly of multimeric enzymes is 
assisted by factors that are not part of the mature enzyme but nevertheless essential in promoting its 
assembly into an active form. The number of assembly factors identified for complex I is growing every 
year but still stays low since only 9 factors were identified among eukaryotes. It is thus highly probable 
that additional assembly factors, encoded by the nuclear genome, are needed for the assembly. This 
hypothesis is supported by the fact that in 60% of patients presenting a complex I pathology, mutations 
cannot be found in the structural or assembly factors known for complex I. Moreover, in patients 
suffering from a mitochondrial disease, the pathogenicity of a given human mitochondrial mutation can 
be difficult to analyze because the mitochondrial genome harbors large numbers of polymorphic base 
changes that have no pathogenic significance. In addition, mitochondrial mutations are usually found in 
the heteroplasmic state, which could hide the biochemical effect of the mutation. Human mitochondrial 
mutations can be reconstructed in the yeast S. cerevisiae except for complex I mutations because S. 
cerevisiae is lacking complex I and oxidizes NADH via a monomeric type-II NADH dehydrogenase. As a 
substitute, bacterial systems have been used to reconstruct human pathogenic mutations but are not 
ideal because the membrane domain of eukaryotic complex I is much more complex than the 
corresponding arm from bacterial complex I (28 subunits versus 7 subunits). 
The first goal of my thesis thus focused on the identification of new assembly factors of complex I, 
using Chlamydomonas reinhartii, a green alga, as an experimental system (realized in collaboration with 
Prof. Hamel, Ohio State University - USA). For that purpose, an insertion library was built that was 
subsequently screened for complex I mutants. I’ve contributed to the construction of the insertion 
mutant library using a hygromycin (an aminoglycoside type antibiotic) resistance cassette and to the 
screening of complex I mutants, based on the fact that these mutants present a reduced growth in 
heterotrophic conditions (dark + acetate as carbon source). Complex I deficiency was found in 6 nuclear 
mutants and named amc1 and amc 3 to 7 (for assembly of mitochondrial complex I). My work was to 
characterize them biochemically and to compare them to amc2 mutant, a nuclear complex I mutant 
previously isolated. These mutants displayed reduced or no complex I activity. Blue native (BN)-PAGE 
and immunoblot analyses revealed that amc3, and  -4 accumulated reduced levels of the complex I 
holoenzyme (950 kDa) while all other amc mutants amc1, -2, -5 to -7 failed to accumulate a mature 
complex. Instead, a 700 kDa subcomplex retaining NADH dehydrogenase activity was observed. Genetic 
analyses established that amc5 and amc7 are alleles of the same locus while amc1–4 and amc6 defined 
distinct complementation groups. So far, our goal was not completely reached because only the locus 
defined by the amc5 and amc7 alleles corresponding to the NUOB10 gene, encoding PDSW, a subunit of 
the membrane arm of complex I, was identified. Unfortunately, loci defined by the others alleles could 
not be easily identified because mutations were not tagged with the resistance cassette. But other 
techniques to retrieve mutations were planned such as whole-genome sequencing. Nowadays, this 
technique becomes easy and affordable using Illumina's sequencing technology. Like this, in 
collaboration with Prof. Denis Baurain (University of Liege), the entire genome of amc4 and amc8 
(coming from another insertion library) mutants were sequenced. I’m currently comparing the entire 
genomes of these two mutants and trying to localize the gene involved in the complex I deficiency.  
The second goal of my project was to propose that the unicellular green alga Chlamydomonas 
could be an attractive eukaryotic system to study heteroplasmic and uncharacterized human 
mitochondrial mutations because (1) respiratory-deficient mutants are viable and mitochondrial 
mutations are found in the homoplasmic state, (2) transformation of the mitochondrial genome is 
feasible, (3) Chlamydomonas complex I is close to that of humans. To illustrate that, we have introduced 
a Leu157Pro substitution in the Chlamydomonas ND4 subunit of complex I of two different recipient 
strains by biolistic transformation, demonstrating that site-directed mutagenesis of the Chlamydomonas 
mitochondrial genome is possible. This substitution did not apparently lead to any respiratory enzyme 
defect when it is present in the heteroplasmic state in a patient presenting chronic progressive external 
ophthalmoplegia. When present in the homoplasmic state in the alga, the mutation does not prevent the 
assembly of the 950 kDa whole complex I which conserves nearly all the NADH dehydrogenase activity of 
the peripheral arm. However, the NADH:duroquinone oxidoreductase activity is strongly reduced, 
suggesting that the substitution could affect ubiquinone fixation to the membrane domain. The in vitro 
defects are correlated in vivo with a decrease in dark respiration and growth rate. 
A side project to the mitochondrial transformation was to analyze ends of the Chlamydomonas 
mitochondrial genome, a small linear molecule of 15.8 kb. Ends are made of 500 pb inverted repeats, 
with 3’end-OH single stranded overhangs of 40 nt. In addition, three repetitions of 86 nt sequence are 
present in the genome: one at each end that comprises the first 40 single-stranded overhangs and 46 nt 
of doubled-stranded DNA as well as one internal. We identified GG quadruplex in these 86 nucleotides 
that could serve to form a T-loop, known to initiate telomeric replication in human chromosomes. In 
addition, a PIF helicase that recognizes and stabilizes GG quadruplex is present in the nuclear genome. 
Prediction location using MITOPROT is mitochondria. Sequencing circular molecules from the 
mitochondrial genome led us to propose that the 86 nt repetition of the left end of the genome (and not 
the 86 nt of the right extremity proposed previously) together with the internal repetition are involved in 
the formation of the T-loop. To investigate the role of this extremity, a series of mitochondrial 
transformations with fragments which comprise or not the 86 nt repetition of the left end of the genome 
was performed. Transformation efficiency dropped dramatically when the single 3’OH extension of this 
repetition was not present. In addition, all the transformants exhibited a restored left end, which 
suggests a copy correction mechanism from the right end. Altogether, these results highlight the role of 
the single 3’OH extension of the left telomere in transformation and probably replication. 
Résumé  
Le complexe I, ou NADH:ubiquinone oxydoréductase, est le point d’entrée des électrons au 
niveau de la chaine mitochondriale de transport d’électrons. En forme de « L » avec une partie 
hydrophobe et hydrophile, ce complexe enzymatique multiprotéique est constitué de 14 sous-unités 
chez les procaryotes et de plus de 40 sous-unités chez les eucaryotes. Ses sous-unités présentent une 
origine génétique double : la majorité est encodée dans le noyau, traduite dans le cytoplasme et dirigée 
dans la mitochondrie à l'aide de signaux spécifiques d'adressage tandis quelques sous-unités, la plupart 
très hydrophobes, sont encodées dans le génome mitochondrial et traduites par les ribosomes présents 
dans la mitochondrie.  
 
Une première problématique est liée à l’assemblage du complexe I. Le nombre de facteurs 
d’assemblage du complexe I identifiés à ce jour est en effet très faible et de nouveaux facteurs restent à 
identifier au niveau du génome nucléaire. 
Une deuxième problématique est liée aux mutations mitochondriales causant des pathologies 
respiratoires. Celles-ci sont difficiles à caractériser chez l’homme. En effet, chaque individu peut 
présenter des variations génétiques au niveau de son génome, n’entrainant pas forcément une 
pathologie. De plus, le plus souvent, les mutations mitochondriales chez l’homme sont à l’état 
hétéroplasmique, c'est-à-dire que dans chaque cellule coexiste un mélange de copies sauvages et 
mutantes du génome, ce qui peut masquer l’effet de la mutation. Pour définir l’impact de telles 
mutations, celles-ci peuvent être reconstruites chez la levure Saccharomyces cerevisiae sauf dans le cas 
de mutations liées au complexe I puisque cette levure en est dépourvue.   
 
Nous avons décidé d’étudier la première problématique chez l’algue verte unicellulaire 
Chlamydomonas reinhardtii, en isolant et caractérisant des mutants nucléaires du complexe I dans le but 
d’identifier de nouveaux facteurs d’assemblage. Pour ce faire, en collaboration avec le Prof. Patrice 
Hamel (Ohio State University), nous avons réalisé une mutagenèse insertionelle du génome nucléaire de 
Chlamydomonas, en utilisant comme marqueur de sélection une cassette de résistance à  l’hygromycine 
(un antibiotique de type aminoglycoside). Les transformants affectés au niveau du complexe I ont été 
sélectionnés sur base d’une croissance lente en conditions hétérotrophes (obscurité + source de 
carbone). Grâce à ce crible, 6 mutants du complexe I ont été isolés et nommés amc1 et amc3 à 7 (pour 
assembly of mitochondrial complex I). Mon travail a consisté par la suite en la caractérisation 
biochimique de ces mutants et en la comparaison avec un mutant nucléaire du complexe I 
précédemment isolé et caractérisé, amc2. Des analyses d’électrophorèse de protéines suivies 
d’immunodétection ont révélé que les mutants amc3 et amc4 présentent un complexe I entièrement 
assemblé mais en quantité réduite, tandis que tout les autres mutants, amc1 et 2, et amc5 à amc7 ne 
présentent pas de complexe I entier, mais un sous-complexe. Les analyses génétiques ont révélé 
qu’amc5 et amc7 sont des allèles d’un même locus, tandis que les autres mutants définissent des 
groupes de complémentations distincts. Jusqu'à présent notre but n’a pas été entièrement atteint 
puisque seule une sous-unité de structure, PDSW encodée par le gène NUOB10, a été identifiée chez 
amc5(-7). Malheureusement nous sommes dans l’incapacité de localiser les autres mutations par des 
techniques traditionnelles (TAIL-PCR) puisque celles-ci ne sont pas liées à la cassette de résistance à 
l’hygromycine. De nouvelles techniques ont donc été envisagées comme le séquençage à haut débit. 
Nous avons choisi la technique de séquençage Illumina pour séquencer entièrement le génome de deux 
mutants. Ceux-ci sont actuellement en cours d’analyse grâce à une collaboration avec le Prof. Denis 
Baurain (Université de Liège).       
La deuxième problématique nous a permis de proposer l’algue verte Chlamydomonas reinhardtii 
comme organisme modèle pour la caractérisation de mutations mitochondriales humaines. Nous avons 
choisi cet organisme puisque (1) les mutants du complexe I sont viables, (2) les mutations 
mitochondriales  sont homoplasmiques, (3) le génome mitochondrial est aisément transformé et enfin 
(4) la composition sous-unitaire du complexe I de Chlamydomonas est proche de celle de l’homme. Pour 
valider notre système, nous avons introduit la substitution Leu157Pro au niveau de la sous-unité 
mitochondriale ND4 du complexe I chez deux souches réceptrices différentes. Cette substitution n’induit 
apparemment pas de déficience au niveau de la chaine mitochondriale de transport d’électrons 
lorsqu’elle est présente à l’état hétéroplasmique chez des patients souffrant d’ophtalmoplégie. Lorsque 
la mutation est à l’état homoplasmique chez l’algue, elle entraine in vitro une diminution de l’activité 
NADH :duroquinone oxydoréductase du complexe I sans pour autant déstabiliser l’enzyme. Cette 
mutation aurait donc un impact sur la fixation de l’ubiquinone à la partie hydrophobe de l’enzyme. Cet 
impact in vitro est corrélé in vivo par une diminution de la respiration cellulaire et de la croissance de 
l’algue.   
Un troisième projet, né de certaines observations au cours d’expériences de transformation du 
génome mitochondrial, a consisté en l’analyse des extrémités télomériques de ce génome. Ce petit 
génome linéaire, d’une taille de 15,8 kb présente des extrémités télomériques gauche et droite  
particulières possédant plusieurs structures dont une extrémité 3’-OH simple brin, une séquence répétée 
de 86 pb et des motifs GG-quadruplexes. Les GG-quadruplex sont connus chez l’homme pour être 
impliqués dans la formation d’une structure T-loop initiant la réplication des extrémités télomériques. 
Nous avons identifié une structure T-loop a sein du génome mitochondrial et des analyses 
bioinformatiques ont permis d’identifier un homologue potentiel d’une PIF hélicase, dont la fonction est 
de reconnaitre et stabiliser les motifs GG-quadruplexes. Nous avons enfin déterminé que l’extrémité 
3’OH simple brin du génome mitochondrial est importante pour l’efficacité de transformation d’une 
souche délétée pour ce télomère. De plus, un système de copie correction est suggéré puisque les 
transformants de chaque catégorie ont récupéré une copie complète de l’extrémité. Ces nouveaux 
résultats mettent en évidence le rôle de l’extrémité 3’-OH simple brin du génome mitochondrial et 
ouvrent une voie à l’étude de la réplication du génome mitochondrial.   
 
1 
 
Table of Content 
CHAPTER 1: INTRODUCTION................................................................................................................ 5 
PART I. THE POWERHOUSE OF THE CELL, MITOCHONDRIA ...........................................................................................7 
I.1. HISTORY ....................................................................................................................................................7 
I.2. METABOLIC REACTIONS IN THE MITOCHONDRIA ..................................................................................................8 
I.2 (1) OXIDATIVE PHOSPHORYLATION SYSTEM .....................................................................................................9 
I.2 (2) THE ENTRY POINT OF OXIDATIVE PHOSPHORYLATION SYSTEM, COMPLEX I ......................................................... 11 
(2) 1. STRUCTURE OF COMPLEX I IN PROKARYOTES .................................................................................................. 11 
(2) 2. COMPLEX I CRYSTALLIZATION IN PROKARYOTES .............................................................................................. 11 
(2) 3. STRUCTURE OF COMPLEX I IN EUKARYOTES ................................................................................................... 12 
(2) 4. COMPLEX I CRYSTALLIZATION IN THE EUKARYOTE, YARROWIA LIPOLYTICA.............................................................. 12 
(2) 5. ASSEMBLY PROCESS OF COMPLEX I ............................................................................................................. 14 
PART II. THE MITOCHONDRIAL GENOME, MTDNA................................................................................................... 16 
II.1. HUMAN MITOCHONDRIAL GENOME ............................................................................................................... 16 
II.1 (1) STRUCTURE ...................................................................................................................................... 16 
II.1 (2) HIGH COPY NUMBER AND HETEROPLASMY ................................................................................................ 17 
II.1 (3) MITOCHONDRIAL MUTATIONS AND DISEASES ............................................................................................ 17 
(3) 1. MITOCHONDRIAL DISEASE SYMPTOMS ( WWW.UMDF.ORG, (LUFT 1994) ............................................................ 17 
(3) 2. MITOCHONDRIAL DISEASES IN AGING .......................................................................................................... 18 
(3) 3. COMPLEX I, THE MOST COMMON SITE FOR MITOCHONDRIAL DISEASES ................................................................. 18 
II.2. CHLAMYDOMONAS MITOCHONDRIAL GENOME ................................................................................................. 19 
II.2 (1) CHLAMYDOMONAS, OUR MODEL ORGANISM ............................................................................................ 19 
II.2 (2) INHERITANCE AND STRUCTURE OF CHLAMYDOMONAS MITOCHONDRIAL GENOME .............................................. 20 
II.2 (3) MUTATION AFFECTING CHLAMYDOMONAS MTDNA ................................................................................... 21 
II.2 (4) MUTANT PHENOTYPE ......................................................................................................................... 22 
II.3. OTHER MITOCHONDRIAL DNA ..................................................................................................................... 23 
II.3 (1) MITOCHONDRIAL DNA IN PLANT .......................................................................................................... 23 
(1) 1. STRUCTURE .......................................................................................................................................... 23 
(1) 2. MUTATION AFFECTING PLANT MTDNA ........................................................................................................ 23 
II.3 (2) MITOCHONDRIAL DNA IN SACCHAROMYCES CEREVISIAE ............................................................................. 23 
(2) 1. STRUCTURE OF  S. CEREVISIAE MITOCHONDRIAL GENOME ................................................................................. 23 
(2) 2. MUTATION AFFECTING S. CEREVISIAE MITOCHONDRIAL GENOME ........................................................................ 24 
PART III. MITOCHONDRIAL TRANSFORMATION ......................................................................................................... 25 
III.1. MTDNA TRANSFORMATION IN SACCHAROMYCES CEREVISIAE .............................................................................. 25 
III.2. MTDNA TRANSFORMATION IN CHLAMYDOMONAS REINHARDTII.......................................................................... 25 
III.3. MTDNA TRANSFORMATION IN PLANT ........................................................................................................... 26 
III.4. MTDNA TRANSFORMATION IN MAMMAL ...................................................................................................... 27 
  
2 
 
PART IV. CHLOROPLAST, THE GREEN ENERGY POWERHOUSE ....................................................................................... 28 
IV.1. HISTORY .................................................................................................................................................. 28 
IV.2. STRUCTURE OF PLASTIDS ............................................................................................................................. 29 
IV.3. DISCOVERY OF CHLOROPLAST DNA, CPDNA ................................................................................................... 29 
IV.4. CHLAMYDOMONAS REINHARDTII CHLOROPLAST GENOME STRUCTURE AND SEQUENCE ............................................... 30 
IV.5. CHLOROPLAST DNA IN LAND PLANT .............................................................................................................. 30 
PART V. CHLOROPLAST TRANSFORMATION ............................................................................................................. 31 
V.1. HISTORY .................................................................................................................................................. 31 
V.2. TRANSFORMABLE PLANT ORGANISMS ............................................................................................................. 31 
V.3. SELECTION FOR CHLOROPLASTIC TRANSFORMATION ........................................................................................... 31 
PART VI. NEXT-GENERATION GENOME SEQUENCING, THE ILLUMINA SEQUENCING ............................................................ 33 
VI.1. SAMPLE PREPARATION AND SEQUENCING PROCEDURE ((JANITZ 2008) AND WWW.ILLUMINA.COM) ............................. 33 
PART VII. OBJECTIVES .......................................................................................................................................... 35 
VII.1. NUCLEAR TRANSFORMATION .................................................................................................................... 35 
VII.1 (1) ISOLATION AND CHARACTERIZATION OF NUCLEAR COMPLEX I MUTANTS IN THE UNICELLULAR GREEN ALGA 
CHLAMYDOMONAS ............................................................................................................................................. 35 
VII.2. ORGANELLE TRANSFORMATION ................................................................................................................ 35 
VII.2 (1) RECONSTRUCTION OF A HUMAN MITOCHONDRIAL COMPLEX I MUTATION IN THE UNICELLULAR GREEN ALGA 
CHLAMYDOMONAS ............................................................................................................................................. 35 
VII.2 (2) ROLE OF THE LEFT TERMINAL REPEAT OF THE CHLAMYDOMONAS MITOCHONDRIAL GENOME IN TRANSFORMATION 
AND REPLICATION ............................................................................................................................................... 36 
VII.2 (3) DEVELOPMENT OF A NEW SELECTABLE MARKER FOR CHLOROPLAST TRANSFORMATION IN CHLAMYDOMONAS........ 36 
CHAPTER 2: RESULTS  Nuclear transformation................................................................................ 37 
PART I. ISOLATION AND CHARACTERIZATION OF COMPLEX I MUTANTS IN THE UNICELLULAR GREEN ALGA CHLAMYDOMONAS 
(BARBIERI, LAROSA ET AL. 2011) .................................................................................................................................. 39 
PUBLICATION #1:  .............................................................................................................................. 41 
A forward genetic screen identifies mutants deficient for mitochondrial complex I assembly in 
Chlamydomonas reinhardtii.  
PART II. ALTERNATIVE STRATEGIES TO RETRIEVE MUTATIONS THAT DO NOT COSEGREGATE WITH TRANSGENE IN FORWARD GENETIC 
SCREEN 59 
II.1. GENETIC ANALYSIS ..................................................................................................................................... 61 
II.2. HIGH THROUGHPUT GENOME SEQUENCING, THE LAST BUT NOT LEAST ALTERNATIVE TO RETRIEVE UNTAGGED GENES IN 
INSERTION MUTANTS .............................................................................................................................................. 63 
II.2 (1) ABANDONED APPROACH ...................................................................................................................... 63 
II.2 (2) IN PROCESS ALTERNATIVE; HIGH THROUGHPUT SEQUENCING ........................................................................ 63 
II.2 (3) RESULTS; MAPPING TO THE REFERENCE GENOME ....................................................................................... 64 
II.2 (4) FIRST STEP, READ COVERAGE ANALYSIS ................................................................................................... 65 
II.2 (5) PERSPECTIVES ................................................................................................................................... 69 
3 
 
CHAPTER 3: RESULTS Organelle transformation; Mitochondria .................................................... 71 
PART I. RECONSTRUCTION OF A HUMAN MITOCHONDRIAL COMPLEX I MUTATION IN THE UNICELLULAR GREEN ALGA 
CHLAMYDOMONAS (LAROSA, COOSEMANS ET AL. 2012) .................................................................................................... 73 
PUBLICATION #2 ................................................................................................................................ 75 
Reconstruction of a human mitochondrial complex I mutation in the unicellular green alga 
Chlamydomonas 
PART II. ROLE OF THE LEFT TERMINAL REPEAT OF THE CHLAMYDOMONAS MITOCHONDRIAL GENOME IN TRANSFORMATION AND 
REPLICATION 93 
PUBLICATION # 3 ............................................................................................................................... 95 
Role of the left terminal repeat of the Chlamydomonas mitochondrial genome in transformation 
and replication.  
CHAPTER 4: RESULTS Organelles transformation; Chloroplast .................................................... 111 
PART I. DEVELOPMENT OF A NEW SELECTABLE MARKER FOR CHLOROPLAST TRANSFORMATION IN CHLAMYDOMONAS (REMACLE, 
CLINE ET AL. 2009) .................................................................................................................................................. 113 
PUBLICATION #4 .............................................................................................................................. 115 
The ARG9 gene encodes the plastid-resident N-acetyl ornithine aminotransferase in the green 
alga Chlamydomonas reinhardtii 
CHAPTER 5: PERSPECTIVES ............................................................................................................. 121 
REFERENCES ..................................................................................................................................... 127 
 
ANNEX # 1: ....................................................................................................................................... 141 
Complexes I in the green lineage 
ANNEX #2: ........................................................................................................................................ 173 
Transformation and nucleic acid delivery to mitochondria 
 
 
 
  
4 
 
 
 
  
5 
 
Chapter 1: Introduction  
  
6 
 
 
 
  
7 
 
PART I. THE POWERHOUSE OF THE CELL, MITOCHONDRIA  
I.1. HISTORY  
Before identifying them as mitochondria, granular structures were already identified in 
the cell in the nineteenth – century and were defined with more than a dozen terms such as 
blepharoblasts, chondrioplasts, fila, fuchsinophilic granules, plastochondria, and so on. In 1888, 
the microscopist R.A. Kollicker microdissecting these granules out of insect muscle and 
observing them to swell in water, reached the conclusion that mitochondria have a membrane. 
In 1890, Altman proposed that these granules were autonomous, elemental living units forming 
bacteria-like colonies in the host cell cytoplasm. An idea ahead of his time! In 1913, granular, 
insoluble subcellular structures were associated with respiration. But another 30-40 years of 
intense and painstaking biochemical analyses were required to characterize the mitochondria as 
the “powerhouse of the cell”.  
Nowadays, technologies to study mitochondria evolved and were improved. Isolation of 
mitochondria, biochemical and microscopy analysis, genome sequencing are now easily feasible. 
This allowed the conclusion that the eukaryotic cell of mammals or plants contains mitochondria 
that originated from an endosymbiotic process that involved an α-proteobacterium (Martin and 
Muller 1998; Gray, Burger et al. 1999).   
  
Figure 1 : Different shapes of mitochondria (A) 
Mitochondria viewed in transmission electron 
microscopy and schematic organization below 
(B) Mitochondria with angular cristae from 
ventricular  cardiac muscle (C) with lamellar 
cristea from fish pseudobranch (D) and with 
tubular cristae in amoeba (Scheffler 2008).  
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These double membrane organelles continuously change shape and position as 
illustrated in our work (See Publication #2 : (Larosa, Coosemans et al. 2012), Fig.4 and 
Supplemental Fig. 2) and contain the complete metabolic machinery for the oxidative 
conversion of pyruvate, fatty acids and amino acids into ATP, the major energy source for the 
cells. This energy is generated thanks to a proton (H+) gradient sustained by the electron 
transport chain localized in the inner membrane of mitochondria.  Their outer membrane is 
fairly smooth and the inner membrane is highly convoluted, forming folds in the matrix called 
cristae (Fig. 1A). Cristae can differ from cell to cell. Angular cristea can be found in ventricular 
cardiac muscle (Fig. 1B), lamellar cristae in fish pseudobranch (Fig. 1C) or tubular cristea in 
amoeba (Fig. 1D) (Scheffler 2008).    
Mitochondria have not a fixed size, but generally are around 1 to 3 um. The number of 
mitochondria in a cell can vary from cell type to cell type, as example the human oocyte is 
estimated to contain more than 100000 mitochondria compared to the unicellular alga 
Chlamydomonas reinhardtii that presents more or less 50 mitochondria.  
Mitochondria are essential subcellular organelles in the vast majority of eukaryotic cells, 
although some eukaryotes such as the microsporidian Trachipleistophora homini, a human 
parasite, do not have apparent mitochondria. These organisms still have remnants of 
mitochondria (hydrogenosomes/mitosomes) in their cytoplasm (Williams, Hirt et al. 2002).  
I.2. METABOLIC REACTIONS IN THE MITOCHONDRIA  
Many reactions taking place inside mitochondria occupy a central position on any 
metabolic chart. Oxidative phosphorylation, fatty acid oxidation and the Krebs cycle 
(tricarboxylic acid cycle) are the defining reactions for mitochondria. Other major pathways or 
cycles include urea cycle, heme and iron-sulfur cluster biosynthesis, part of the reactions leading 
to steroid, dolichol and ubiquinone biosynthesis and the synthesis of a specific lipid, cardiolipin, 
which is found almost exclusively in mitochondrial membrane.  
Krebs cycle takes place in the mitochondrial matrix and involves 8 well characterized 
steps. The products coming from the Krebs cycle, obtained by the degradation of one molecule 
of acetyl-CoA, are two CO2 molecules, three molecules of reduced nicotinamide adenine 
dinucleotide (NADH) and one reduced molecule of flavine adenine dinucleotide (FADH2). 
The process of mitochondrial fatty acid oxidation is termed β-oxidation since it occurs 
through the sequential removal of 2-carbon units by oxidation at the β-carbon position of the 
fatty acyl-CoA molecule. β-oxidation also contributes to the reducing equivalent pool but less 
than Krebs cycle. In fact, in each round, one molecule of FADH2, one molecule of NADH, and one 
molecule of acetyl-CoA are produced.  
Another process, not present in the mitochondria but in cytoplasm, also contributes to 
the production of reducing equivalents, the glycolysis. For the split of 1 glucose molecule, 2 
molecules of ATP and 2 molecules of NADH are produced.    
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I.2 (1) OXIDATIVE PHOSPHORYLATION SYSTEM  
The major process in mitochondria is the oxidative phosphorylation (OXPHOS). This 
process comprises an electron-transfer chain catalyzed by 4 multiprotein complexes (I, II, III and 
IV) that is driven by substrate oxidation and is coupled to the synthesis of ATP (complex V), the 
process being called respiration (Fig. 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This electrons transfer chain is localized in the inner membrane of mitochondria. The 
reactions that occur are oxidoreductions of reducing equivalents coming from Krebs cycle, 
glycolysis or β-oxidation. NADH is oxidized by the NADH:ubiquinone oxidoreductase (complex I 
in Fig. 2) and FADH2 by the succinate: ubiquinone oxidoreductase (complex II in Fig. 2). These 
electrons are transferred to the ubiquinone pool (QH2 in Fig. 2) and then to cytochrome c via the 
ubiquinol:cytochrome c oxidoreductase  (complex III in Fig. 2). The last step of this chain is 
accomplished by the cytochrome c oxidase (complex IV in Fig. 2) that transfers electron to the 
final acceptor, oxygen. The oxidoreduction reactions mediated by complex I, III and IV are 
coupled with proton (H+) transfer from the matrix to intermembrane space, leading to the 
generation of a proton gradient used for the production of ATP by complex V (ATP synthase in 
Fig. 2) (Wikstrom and Verkhovsky 2007; Belevich and Verkhovsky 2008; Zickermann, Drose et al. 
2008; Zickermann, Kerscher et al. 2009). In plants and microorganisms alternative pathways are 
present. Alternative internal NADH dehydrogenases (ND in Fig. 2) also contribute to the 
reduction of the ubiquinone pool, bypassing the activity of complex I without being coupled to 
proton translocation. They are called type II NADH dehydrogenase (Kerscher 2000) compared to 
the type I that is complex I. In fermenting yeasts like Saccharomyces cerevisiae that do not 
contain complex I (Ohnishi, Kawaguchi et al. 1966), they are the only enzymes that feed 
reducing equivalents from NADH into the respiratory chain. Another alternative pathway is 
realized by the alternative oxidase (AOX in Fig. 2) that can bypass complex III and IV transferring 
electrons directly from ubiquinone to oxygen. These alternatives pathway are not coupled to 
proton transfer from the matrix to intermembrane space.  
 
Figure 2 : Schematic organization of the electron transfer chain in the plant mitochondrial inner 
membrane (adapted from (Remacle, Barbieri et al. 2008)).  
Complex I 
4 
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Figure 3 : (A) The structure of the entire complex I from T. thermophilus and (B) proposed model of proton translocation by 
complex I in T.Termophilus (From (Efremov, Baradaran et al. 2010)).  In (A) each subunit is colored differently and indicated, 
in (A) and (B) Fe-S clusters are shown as red and yellow spheres and FMN as magenta spheres. In the model proposed in (B) 
NADH, via FMN (magenta), donates two electrons to the chain of Fe-S clusters (red and yellow spheres), which are passed 
on (blue line), via terminal cluster N2, to the quinone (dark blue, moved out of the membrane by about 10 angstroms). 
Electron transfer is coupled to conformational changes (indicated by arrows) in the hydrophilic domain, observed for Nqo4 
four-helix bundle (green cylinders) and Nqo6 helix H1 (red). These changes are transmitted to the amphipathic helix HL 
(magenta), which tilts three discontinuous helices (red) in antiporter-like subunits, changing the conformation of ionizable 
residue inside respective proton channels, resulting in translocation of three protons. The fourth protons are translocated at 
the interface of the two main domains.  
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I.2 (2) THE ENTRY POINT OF OXIDATIVE PHOSPHORYLATION SYSTEM, COMPLEX I  
NADH generated in catabolic pathways described in I.2, fed the oxidative phosphorylation 
system via NADH:ubiquinone oxidoreductases and alternative NADH dehydrogenases. 
NADH:ubiquinone oxidoreductase or complex I was first described in mitochondria (Hatefi, 
Haavik et al. 1962), but it is also found in many eubacteria where it is frequently termed NADH 
dehydrogenase-1 or NDH-1 (Matsushita, Ohnishi et al. 1987; Friedrich 1998; Yagi, Yano et al. 
1998). This part will focus on complex I composition, crystallization and assembly and is 
complemented by a review paper in Annex 1 (Remacle, Hamel et al. 2012 ). 
 
(2) 1. STRUCTURE OF COMPLEX I IN PROKARYOTES 
As for other respiratory chain complexes, prokaryotic complex I represents the minimal form 
of the enzyme. It has an L-shape with an hydrophilic and a hydrophobic domain , and comprises 
14 subunits, whose homologues are also part of mitochondrial complex I in all eukaryotes, that 
carry all redox centers (Weidner, Geier et al. 1993), flavine mononucleotide (FMN), and up to 
nine iron-sulfur clusters (Ohnishi 1998; Hinchliffe and Sazanov 2005); these “central” subunits 
are thus sufficient to perform all bioenergetic functions required for a proton-pumping 
NADH:ubiquinone oxidoreductase complex. In bacteria, these 14 genes are organized in a single 
operon –nuo (NADH:ubiquinone oxidoreductase) or nqo (NADH:quinone oxidoreductase) 
depending on the species (Yagi and Matsuno-Yagi 2003) and encode the hydrophilic and 
hydrophobic subunits of the enzyme (Friedrich 1998). Recently, an additional subunit (Nqo15) 
was shown to co-purify with the enzyme core in the bacteria Thermus thermophilus. This 
subunit is not encoded in the operon and seems to be only present in the closest relatives of T. 
thermophilus (Hinchliffe, Carroll et al. 2006). 
(2) 2. COMPLEX I CRYSTALLIZATION IN PROKARYOTES 
In 2006 (Sazanov and Hinchliffe 2006), the crystallization of the hydrophilic domain of T. 
thermophilus, allowed the visualization of eight subunits containing all the redox centers of the 
enzyme including nine iron-sulfur clusters (versus eight in eukaryote complex I) in this domain. 
More recently, in 2010 (Efremov, Baradaran et al. 2010), the structure of membrane domain of 
Thermus thermophilus was resolved at 4.5 A° showing that in total the membrane domain 
contains 63 TM helices. 
In this same study (Efremov, Baradaran et al. 2010) an alpha-helical model of the membrane 
domain in E. coli showed that the antiporter-like subunits NuoL/M/N each contain 14 conserved 
transmembrane (TM) helices. Two of them are discontinuous, as in some transporters. 
Unexpectedly, subunit NuoL also contains a 110-A° long amphipathic a-helix, spanning almost 
the entire length of the domain.  
These crystallization studies permitted to visualize the electron pathway. NADH, via FMN 
(magenta in Fig. 3A and B), donates two electrons to the chain of Fe-S clusters (red and yellow 
spheres in Fig. 3A and B), which are passed on (blue line in Fig. 3B), via terminal cluster N2, to 
the quinone (dark blue in Fig. 3B). Electron transfer is coupled to conformational changes 
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(indicated by the 2 black arrows in Fig. 3B) in the hydrophilic domain, observed for Nqo4 four-
helix bundle (green cylinders in Fig. 3B) and Nqo6 helix H1 (red in Fig. 3B). These changes are 
transmitted to the amphipathic helix HL (magenta in Fig. 3B), which tilts three discontinuous 
helices (red in Fig. 3B) in antiporter-like subunits, changing the conformation of ionizable 
residue inside respective proton channels, resulting in translocation of three protons. The fourth 
protons are translocated at the interface of the two main domains. 
Such analyses reveal new aspects of the enzyme mechanism. The terminal cluster N2 is 
coordinated, uniquely, by two consecutive cysteines. A novel subunit was identified, Nqo15, and 
has a similar fold to the mitochondrial iron chaperone frataxin, and it may be involved in iron-
sulfur cluster regeneration in the complex. Moreover, strong clues about the coupling 
mechanism appear; the conformational changes at the interface of the two main domains may 
drive the long amphipathic α-helix of NuoL in a piston-like motion, tilting nearby discontinuous 
TM helices, resulting in proton translocation. 
(2) 3. STRUCTURE OF COMPLEX I IN EUKARYOTES  
In addition to these 14 core subunits, mitochondrial complex I contains up to 32 additional 
subunits resulting in a total molecular mass of up to  1000 kDa (Carroll, Fearnley et al. 2003; 
Hirst, Carroll et al. 2003). The function of these “accessory” subunits is largely unknown. 
Nevertheless insight into the role of complex I subunits has been obtained, by characterizing 
complex I mutants in Neurospora crassa (Marques, Duarte et al. 2005).  
Complex I comprises 45 subunits in bovine heart (Fearnley, Carroll et al. 2001; Hirst, Carroll 
et al. 2003), at least 42 subunits in the vascular plants Arabidopsis thaliana and Oryza sativa 
(Heazlewood, Howell et al. 2003; Meyer, Heazlewood et al. 2007), and at least 39 and 37 
subunits in the fungi Neurospora crassa (Videira and Duarte 2002) and Yarrowia lipolytica, 
respectively (Abdrakhmanova, Zickermann et al. 2004). In the green alga Chlamydomonas 
reinhardtii, complex I has an apparent molecular mass of 950 – 1000 kDa and is composed of 42 
subunits ranging in size from 7 to 77 kDa (van Lis, Atteia et al. 2003; Cardol, Vanrobaeys et al. 
2004). A recent study proposed that mitochondrial complex I is highly conserved among 
eukaryotes, with more than 40 homologous components shared between the different 
kingdoms (plants, mammals, fungi and algae) (Cardol 2011).  
(2) 4. COMPLEX I CRYSTALLIZATION IN THE EUKARYOTE, YARROWIA LIPOLYTICA 
Complex I couples electron transfer to ubiquinone with proton pumping across the inner 
mitochondrial membrane. With a stoichiometry of four protons to two electrons (4H+/2e-), it 
contributes for about 40% of the proton motive force that drives adenosine 5´-triphosphate 
(ATP) synthesis by ATP synthase (Wikstrom 1984; Brandt 2006). 
The crystallization of Yarrowia lipolytica complex I was obtained in 2010 by Hunte et al. 
(Hunte, Zickermann et al. 2010). They showed that the molecule is L-shaped, with an angle 
between the two arms of about 100° (Fig. 4A and B). The membrane arm has a length of ~180 Å, 
and the distance between the tip of the peripheral arm and the bottom of the membrane arm is 
~190 Å (Fig. 4B). At a resolution of 6.3 Å, many secondary structure elements and especially α-
helical transmembrane segments were clearly recognized in the electron density (Fig. 4B).  
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Mitochondrial complex I is organized in four functional modules, N, Q, PP and PD (Hunte, 
Zickermann et al. 2010) (Fig. 4A). The positions of all eight iron-sulfur cofactors were localized in 
the peripheral arm in the N and Q modules (Fig. 4A and B). The distances between the iron-
sulfur clusters are similar to those reported for the hydrophilic fragment of bacterial complex I 
(Fig. 4B) (Hinchliffe and Sazanov 2005). Seven of these clusters constitute a continuous electron 
wire between the catalytic sites. Compared with the bacterial fragment, the Q and N modules 
are opened 3° wider and turned slightly, relative to each other. This reorientation does not 
affect the distances for electron transfer between the two parts of complex I.  
 
Figure 4 : Schematic model of complex I and its pumping modules (Hunte, Zickermann et al. 2010). (A) Complex I can be 
dissected into four functional modules (Hunte, Zickermann et al. 2010) and allows the assignment of subunits and proton pumps 
to the proximal (PP, green) and distal (PD, cyan) domains of the membrane arm. The FMN containing N-module (light yellow), 
the Q-module harbouring the ubiquinone binding site (dark yellow), the chain of seven iron-sulfur clusters (orange spheres), and 
the extended transmission element (magenta) are indicated. (B) Well-defined electron density corresponding to one molecule of 
L-shaped complex I shown in side view with the membrane arm displayed horizontally, the positions of eight iron-sulfur clusters 
of the peripheral arm is displayed in yellow and shown enlarged and slightly turned for better visualization of all clusters in the 
insert. Center-to-center distances are given in angstroms. Solid white lines indicate that these distances are short enough for 
physiological electron transfer; otherwise, dashed lines are used. 
 
The 180 A° long membrane arm or P module of complex I is subdivided into two subdomains 
of approximately equal size, called the proximal or PP and the distal or PD module (Fig. 4A) 
(Hunte, Zickermann et al. 2010). The entire P module is composed of 17 membrane-integral 
subunits with 71 α-helical transmembrane segments of different lengths, tilts, and curvatures 
into continuous elongated electron density (Zickermann, Kerscher et al. 2009; Hunte, 
Zickermann et al. 2010). The proton pumping must occur somewhere in the membrane arm, but 
how it occurs is still a big question but these years more and more details are emerging about 
this process. In fact, ND2, ND4, and ND5, localized in the PD module, show homology to subunits 
Figure 4 
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of bacterial sodium-proton antiporters (Mathiesen and Hagerhall 2002). These subunits are 
proposed as proton-translocating subunits in the PD domain. Recently, Drose et al. (Drose, Krack 
et al. 2011) analyzed a Yarrowia lipolytica mutant lacking the PD module, where are found ND4 
and ND5. This mutant was still catalytically active but it pumped only half the number of protons 
compared to the full complex. This indicates that complex I has two functionally distinct pump 
modules operating in its membrane arm like represented in Fig. 4A.  
(2) 5. ASSEMBLY PROCESS OF COMPLEX I   
The number of assembly factors identified for complex I is growing every year but still stays 
low since only 9 factors for assembly complex I (±40 subunits) were identified in comparison to 
the 20 chaperones involved in the assembly process of complex IV, composed of only 12 
subunits (Hoober 1989).   
The first two assembly factors, CIA30 and CIA84, were identified in N. crassa. CIA30 and 
CIA84 are chaperones that have been shown to be directly involved in the assembly process of 
complex I, through their association with a large membrane domain in a mutant unable to 
assemble the holoenzyme (Kuffner, Rohr et al. 1998). CIA30 is well conserved among eukaryotes 
and homologs were found in vascular plants, algae but also in humans (Table 1). In fact, in 
humans, CIA30 plays a crucial role in the early assembly of complex I and mutations in the CIA30 
encoding gene are responsible for a complex I mitochondrial disease (Dunning, McKenzie et al. 
2007). To date, CIA84 seems specific to N. crassa and was neither found in vascular plants nor in 
algae. In 2008, Ind1 was identified as participating in the assembly of Fe–S cofactors and 
subunits of complex I in the yeast Y. lipolytica (Bych, Kerscher et al. 2008). As expected for such 
a role, Ind1 is well conserved among eukaryotes. In humans, where it is also known as NUBPL, it 
is critically required for the assembly of complex I with a possible role in the delivery of one or 
more Fe/S clusters to complex I subunits (Sheftel, Stehling et al. 2009). In the past few years, the 
discovery of six assembly factors (C20orf7, C8ORF38, FOXRED1, NDUFAF2, NDUFAF3, and 
NDUFAF4) provided a significant insight into the assembly process of human complex I. 
Bioinformatics analysis reveals that homologs of these assembly factors are detected in algae 
and vascular plants, except for NDUAF2 and NDUAF4 (Table 1) (Remacle, Hamel et al. 2012 ). 
C20orf7 is peripherally associated with the matrix side of the mitochondrial inner membrane 
and plays a crucial role in the early stage of complex I assembly but in a different manner than 
CIA30 (Sugiana, Pagliarini et al. 2008). Knocking-down C8orf38 in mice resulted in a reduction of 
both abundance and activity of complex I (Pagliarini, Calvo et al. 2008). FOXRED1 is an 
uncharacterized protein that derives its name from a FAD-dependent oxidoreductase protein 
domain. A lack of FOXRED1 leads to severe complex I deficiency in humans, but its role in 
biochemical activity and in the assembly process remains unclear. Four human homologs of 
FOXRED1 (DMGDH, SARDH, PIPOX and PDPR) perform redox reactions in amino acid catabolism, 
suggesting a potential link between amino acid metabolism and complex I (Calvo, Tucker et al. 
2010). NDUFAF2, also known as B17.2L is a paralog of a complex I subunit (B17.2), which is not 
incorporated into the holoenzyme, and plays a role in a late step of the assembly/stability of 
complex I (Vogel, van den Brand et al. 2007). Recent studies showed that NDUFAF3 and 
NDUFAF4 cooperate from early to late stages of complex I assembly in association with at least 
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the highly conserved subunits NDUFS2, NDUFS3, and NDUFS8, and non-core subunit NDUFA5 
(Saada, Vogel et al. 2009).   
Table 1 : Assembly factors in human, higher plants and C. reinhardtii (Remacle, Hamel et al. 
2012 ) 
 
Complex I Assembly Factor 
 
Function Reference 
H. sapiens Higher plants   C. reinhardtii 
 
 
 
NDUFAF1 
(CIA30) 
CIA30 
(AT1G17350) 
NUOFAF1 
Chaperone 
(early assembly) 
(Kuffner, Rohr et al. 1998) 
NUBPL (Ind1) INDL Ind1 
Assembly of Fe–S 
cofactors 
(Bych, Kerscher et al. 2008) 
Foxred1 
NP_180034 
Sarcosine oxidase 
family protein 
XP_001692123 
FAD-dependent 
oxidoreductase 
Redox reactions (Calvo, Tucker et al. 2010) 
C8ORF38 Os06g0104100 XP_001693265 
Abundance and activity 
of complex I 
(Pagliarini, Calvo et al. 2008) 
C20ORF7 OsI_37783 XP_001693605 
Assembly early stage of 
complex I 
(Sugiana, Pagliarini et al. 2008) 
NDUFAF2 
(B17.2L) 
- - 
Chaperone 
(late assembly) 
(Vogel, van den Brand et al. 
2007) 
NDUFAF3 OsJ_32539 XP_001702394 Cooperation between 
NDUFAF3 and 
NDUFAF4 from early to 
late stages complex I 
assembly 
(Saada, Vogel et al. 2009) NDUFAF4 
(C6ORF66) 
- XP_001701912 
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PART II. THE MITOCHONDRIAL GENOME, MTDNA  
Mitochondria are semi autonomous organelles possessing their own genome, the 
mitochondrial DNA (mtDNA). The first complete mitochondrial genome to be sequenced was 
the human one (Anderson, Bankier et al. 1981) and soon thereafter other mitochondrial 
genome sequencings were accomplished.  
Since mtDNA were smaller than nuclear DNA, it was thus obvious that a limited number of 
genes could be present in the mtDNA. In fact, the vast majority of the approximately 1000 
proteins that make up the mitochondrial proteome is encoded by nuclear genes, while a small 
number of protein coding genes have been retained in the mitochondrial genome during the 
evolution of eukaryotic cells: 13 in humans, 8 in Saccharomyces cerevisiae or in Chlamydomonas 
reinhardtii and as little as 3 in the protist Plasmodium falciparum (Gray, Burger et al. 1999).  
II.1. HUMAN MITOCHONDRIAL GENOME  
II.1 (1) STRUCTURE 
Human mitochondrial DNA is a 
circular double-stranded molecule of 16569 
base pairs (bp) in length that codes for 13 
subunits of the oxidative phosphorylation 
system, 2 ribosomal RNAs (rRNAs), and 22 
transfer RNAs (tRNAs) (Fig. 5) (Anderson, 
Bankier et al. 1981). It is present in hundreds 
to thousands of copies in each cell. MtDNA 
consists predominantly of coding DNA, with 
the exception of a 1100-bp long fragment 
the displacement-loop (D-Loop) (Fig. 5). 
Human mtDNA have 2 origins of replication, 
one responsible for each strand. The leading 
strand has historically been termed the 
heavy (H) strand because of its greater 
intrinsic buoyant density in alkaline cesium 
chloride gradient. Therefore, the opposite 
strand has been termed the light (L) strand. 
The two origins where thus named OH and OL 
for the heavy and the light strand (Fig. 5). OH 
is located in the D-Loop and OL in a cluster of 
five tRNA genes.  
  Figure 5 : Human mitochondrial genome map 
(www.mitomap.com ). 
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Evolutionary studies of human mtDNA are expanded due to unique features that make it 
particularly amenable. These features include a high copy number, maternal inheritance, lack of 
recombination, and a generally higher mutation rate than found in nuclear DNA. 
II.1 (2) HIGH COPY NUMBER AND HETEROPLASMY   
MtDNA is present in high copy number in human cells. The average somatic cell has just 
two copies of any given nuclear gene, but hundreds to thousands of copies of mtDNA (Robin 
and Wong 1988). This property complicates the population genetics of mtDNA because there 
are several levels at which populations of mtDNA molecules can be defined: within a single 
mitochondrion, within a single cell, within a particular tissue, within an individual, and within a 
group of individuals (the traditional definition of a population). The multiple copies of the 
mtDNA genome within an individual don’t need to be all identical; the existence of different 
mtDNA types within an individual is known as heteroplasmy.  
II.1 (3) MITOCHONDRIAL MUTATIONS AND DISEASES  
In the late 1980s, human pedigrees with mtDNA mutation and a phenotype were 
discovered and termed “mitochondrial disease” (Holt, Harding et al. 1988; Wallace, Singh et al. 
1988). Soon after that, it was recognized that such diseases were more common than expected 
with a prevalence of 1/7634 (Thorburn 2004). Defects in the oxidative phosphorylation system, 
metabolic pathway, DNA replication and maintenance are all leading to pathologies where the 
energy metabolism is affected. Initially, mitochondrial diseases were characterized by a partial 
defect in oxidative phosphorylation due to mtDNA mutations, but it is obvious that nuclear 
mutations could also lead to defective electron transport and ATP synthesis. Such mutations 
should follow mendelian genetics in a pedigree. 
(3) 1. MITOCHONDRIAL DISEASE SYMPTOMS ( WWW.UMDF.ORG, (LUFT 1994)  
 The clinical manifestations of mitochondrial pathologies are variable, variating from mild 
to severe. Often, such pathologies involved skeletal muscle and/or central nervous system 
trouble such as in one mitochondrial disease called Chronic Progressive External 
Ophthalmoplegia Syndrome (CPEO). In this pathology, visual myopathy, retinitis pigmentosa and 
dysfunction of the central nervous system are associated. Another common pathology due to 
mitochondrial deficiencies is the MELAS syndrome, for Mitochondrial Encephalomyopathy, 
Lactic Acidosis and Strokelike Episodes. This syndrome is linked to progressive 
neurodegenerative disorder with typical onset between the ages of 2 and 15, although it may 
occur in infancy or as late as adulthood. Initial symptoms may include stroke-like episodes, 
seizures, migraine headaches, and recurrent vomiting. Usually, the patient appears normal 
during infancy, although short stature is common. 
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(3) 2. MITOCHONDRIAL DISEASES IN AGING  
Mitochondrial diseases have now been found to occur as secondary phenomena in aging 
cells as well as in age-related degenerative diseases such as Parkinson, Alzheimer, Huntington 
diseases, amyotrophic lateral sclerosis and cardiomyopathies, atherosclerosis, and diabetes. 
Manifestations of both the primary and secondary mitochondrial diseases are thought to result 
from the production of oxygen free radicals, ROS. With the increased understanding of the 
mechanisms underlying the mitochondrial dysfunctions, some therapeutic strategies are based 
mostly on the administration of antioxidants, replacement of cofactors, and provision of 
nutrients. But at this time, there are no cures yet for mitochondrial disorders or for alleviating 
symptoms and slowing down the progression of the disease. 
(3) 3. COMPLEX I, THE MOST COMMON SITE FOR MITOCHONDRIAL DISEASES  
Complex I, the first step of the oxidative phosphorylation system, is the most common 
site for mitochondrial abnormalities, representing as much as one third of the respiratory chain 
deficiencies. This can probably be explained because complex I is the largest enzymatic complex 
of this system and because mutations in complex I are less drastic than mutations in complex III 
or IV. Indeed, complex III and IV act in parallel, which means that losing the proton pumping site 
of complex III also implies losing that of complex IV. In contrast, in the case of complex I 
deficiency, only one proton pumping site is lost.  
A number of specific mitochondrial disorders have been associated with complex I 
deficiencies including: Leber’s hereditary optic neuropathy (LHON), MELAS and Leigh Syndrome 
(LS). Most cases of complex I deficiencies result from autosomal recessive inheritance 
(combination of defective nuclear genes from both the mother and the father). Less frequently, 
the disorder is maternally inherited or sporadic and the genetic defect is in the mitochondrial 
DNA. Furthermore, in 60% of the cases linked to complex I deficiency, the mutations cannot be 
identified in known genes, nuclear or mitochondrial, related to complex I. This suggests that 
these mutations are in unknown genes related to complex I. These unidentified mutations could 
be present in unidentified complex I assembly factors. 
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II.2. CHLAMYDOMONAS MITOCHONDRIAL GENOME 
II.2 (1) CHLAMYDOMONAS, OUR MODEL ORGANISM  
Our model organism is the unicellular green alga Chlamydomonas reinhartii (Fig. 6), a 
Chlorophyceae of about 10 µm that offers a simple life cycle, easy isolation of mutants, and a 
growing array of tools and techniques for biochemical, metabolic and molecular genetic studies 
(Harris 2001).  
Widely distributed worldwide in soil and fresh water, Chlamydomonas swim thanks to its 
two anterior flagella using a breast-stroke type motion. The alga is enclosed within a wall 
consisting of hydroxyproline-rich glycoproteins and possesses an "eye" that perceives light (Es in 
Fig. 6), several mitochondria (M in Fig. 6) and a big chloroplast horse-shoe shaped (Chl in Fig. 6). 
The mitochondrial and chloroplastic genomes are fully sequenced and annotated (15.8 kb for 
mitochondria; GenBank accession U03843 (Boynton and Gillham 1996)  and 203.8 kb for 
chloroplast;  GenBank accession number NC_005353(Maul, Lilly et al. 2002)). Genetic analysis 
revealed 17 linkage groups for the nuclear genome. This genome of 120-megabases is GC-rich 
(62%) and is also fully sequenced and annotated (Merchant, Prochnik et al. 2007). 
 Life cycle is well defined. Vegetative cells are haploid. When deprived of nitrogen, cells 
differentiate into isogametes of opposite mating types (mt+ and mt-) that can fuse to become  
diploid zygospores. Zygospores develop a hard outer wall that protects from adverse 
environmental conditions. When conditions improve, the diploid zygotes undergo meiosis and 
release four haploid meiotic products that resume the vegetative life cycle. 
A useful tool of this alga is that it can grow on a simple medium of inorganic salts, using 
photosynthesis to provide energy (phototrophic growth) but also in total darkness if acetate is 
provided as an alternative carbon source (heterotrophic growth). Mixotrophic growth is also 
possible using both phototrophic and heterotrophic growth at the same time. (more 
information on www.chlamy.org)   
Among the principal areas of current 
investigation using this model system are flagellar 
structure and function, genetics of basal bodies 
(centrioles), chloroplast biogenesis, photosynthesis, light 
perception, cell-cell recognition, and cell cycle control.  
 
 
 
 
Figure 6 : Representation of the ultrastructure  of a Chlamydomonas cell. 
Cell length, 10 µm; BB, basal bodies; Chl, chloroplast; Cv, contractile  
vacuole; Cw, cell wall; Er, endoplasmic reticulum; Es, eyespot; F, flagella; G, 
Golgi apparatus; L, lipid body; Mi, mitochondria; N, nucleus; No, nucleolus; 
P,  pyrenoid; r, ribosomes; S, starch grain; v, vacuole. From (Harris 2001) 
 
  
Figure 6 
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II.2 (2) INHERITANCE AND STRUCTURE OF CHLAMYDOMONAS MITOCHONDRIAL GENOME   
The Chlamydomonas mitochondrial genome was first characterized in term of buoyant 
density (1,706g/ml in CsCl), melting temperature (87,9°C in standard saline citrate), kinetic 
complexity (9,78x106 Daltons) and physical conformation (99% linear, <1% open and closed 
circular molecules) (Ryan, Grant et al. 1978). The genome is a multicopy system of around 50 to 
100 copies organized into about 20-30 nucleoids (Hiramatsu, Misumi et al. 2006). The nucleoids 
change in size and shape during the cell cycle and are present in mitochondria. Mitochondria 
also change their organization to appear as thick tubular network to highly branched expansions 
in cytoplasm,  sometimes resembling a single large mitochondria, thick corded bodies or small 
lumps forms (see Publication #2 (Larosa, Coosemans et al. 2012) Fig. 4 and Supplemental Fig. 
2)). 
The heredity of Chlamydomonas mitochondrial genome is uniparental and coming from 
the mt- parent. In the meiotic products, recombination is never detected. In contrast, 
homologous mtDNA recombination is detected in mitotic zygotes that do not undergo meiosis. 
In such zygotes, mtDNA is transmitted by both parents and recombination between the parental 
genomes is frequent (Remacle, Bovie et al. 1990; Remacle and Matagne 1993). This 
demonstrates that enzymes involved in homologous recombination are active in 
Chlamydomonas mitochondria. Segregation of the mtDNA occurs in these mitotic zygotes and 
their progeny and after 15–20 divisions, most of the diploid cells are homoplasmic for a mtDNA, 
either recombined or parental. 
  The mitochondrial genome of C. reinhardtii is a 15.8-kb linear molecule characterized by 
low gene content, very short intergenic sequences and no introns. Thirteen genes are present in 
the Chlamydomonas mtDNA : five mitochondrial nd genes encoding subunits of complex I (nd1, 
nd2, nd4, nd5 and nd6), the cob gene encoding the apocytochrome b of complex III (cob), the 
cox1 gene encoding subunit 1 of complex IV (cox1), the rtl gene encoding a reverse transcriptase 
like protein, three genes encoding transfer RNA (tRNA) (trnW, trnQ, trnM) and the genes 
Figure 7 : Physical map of the 15.8 kb linear mitochondrial genome (GenBank accession U03843)(adapted from (Boer and Gray 
1988). The two thin arrows indicate the long terminal inverted repeats of 531-532 nucleotides in size. The three copies of the 
86-bp repeat are represented by flags. The two terminal ones are characterized by single stranded long extensions of 39-41 
nucleotides. Genes are indicated by rectangles: cob, apocytochrome b; nd1, nd2, nd4, nd5, nd6 subunits of NADH 
dehydrogenase; cox1, subunit I of cytochrome oxidase; rtl, reverse transcriptase-like gene; W, gene for tryptophan-tRNA; Q, 
glutamine-tRNA; M, methionine-tRNA; S1, S2, S3, S4, fragments of the small ribosomal RNA; L1, L2a, L2b, L3a, L3b, L4, L5, L6, L7, 
L8 fragments of the large ribosomal RNA . The two thick arrows above the figure indicate the bidirectional origin of 
transcription.  
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encoding the ribosomal RNAs (rRNAs) (Fig. 7). The rRNA genes are discontinuous and split into 
four small subunit (S) and eight large subunit (L) modules (Fig. 7), interspersed with one another 
and with protein and tRNA genes. The small rRNA segments of the two ribosomal subunits are 
thought to interact by the way of extensive intermolecular pairing to form conventional rRNA 
molecules (Boer and Gray 1988).  
Ends are made of 500 bp inverted repeats, with 3’ end-OH single stranded overhangs of 
40 nt. In addition, three repetitions of 86 nt sequence are present in the genome: one at each 
end that comprises the first 40 single-stranded overhangs + 46 nt of doubled-stranded DNA and 
one internal (Vahrenholz, Riemen et al. 1993). These copies are represented by flags in (Fig. 7) 
How the mtDNA is replicated in Chlamydomonas is still not known. A recombination 
mediated model based on the presence of the three 86 nt repeat sequences and a reverse 
transcriptase-mediated model have been proposed for the replication of the termini of the 
linear mtDNA (Vahrenholz, Riemen et al. 1993).  
Both strands of the mtDNA encode genetic information and one bi-directional 
transcription origin is present in the short intergenic region between nd5 and cox1 (Fig. 7) (Gray 
and Boer 1988). Two primary co-transcripts are generated from this transcription origin and 
process to yield the mature RNAs. A minimum of 23 tRNAs is needed to translate the genetic 
information (Boer and Gray 1988). As only 3 tRNAs are encoded by the mtDNA in 
Chlamydomonas, most of the tRNA used in the organelle are imported from the cytosol 
(Vinogradova, Salinas et al. 2009).  
II.2 (3) MUTATION AFFECTING CHLAMYDOMONAS MTDNA  
Intercalating dyes, such as acriflavin (AF) and ethidium bromide (EB), induce non-
Mendelian, respiratory deficient (petite) mutations in the facultative anaerobe, the yeast 
Saccharomyces cerevisiae (Slonimski, Perrodin et al. 1968). Petite mutants are unable to respire 
because they have defective mitochondria in which essential components of the respiratory 
electron transport chain including cytochrome oxidase and cytochrome b are missing.  
Same treatments were applied on Chlamydomonas reinhardtii. AF treatment 
preferentially inhibits the growth of C. reinhardtii on a carbon source which must be respired. AF 
induces a class of lethal minute colony mutations that are incapable of further division even 
upon replating, while wild type cells would undergo future mitotic divisions. As the two 
intercaling dyes cause specific elimination of mtDNA, the lethal phenotype was correlated with 
the loss of the mitochondrial genome (Gillham, Boynton et al. 1987).  
 In addition to lethal minute colonies, AF and EB also induce a low percentage of viable 
mutants impaired in respiratory functions (Matagne, Michel-Wolwertz et al. 1989; Dorthu, Remy 
et al. 1992). As the mtDNA in inherited by the mt- parent, respiratory deficient mutants in which 
mtDNA is affected are thus called dum (for dark uniparental transmission by the mt- parent).   
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II.2 (4) MUTANT PHENOTYPE 
Several mutations altering the mt cob, cox1 and nd genes have been isolated after 
random mutagenesis with acriflavine (Remacle, Duby et al. 2001). Phenotypically, the mutants 
in the cob (such as dum11 in Fig. 8) and cox1 genes have lost the capacity to grow under 
heterotrophic conditions (Fig. 8B) i.e. in the dark, with acetate as carbon source because they 
lack the cytochrome pathway of respiration. In contrast, mutants altered in the nd genes (such 
dum17 in Fig. 8), which encode subunits of complex I, are able to grow in the dark (Fig. 8B), but 
considerably more slowly than the wild-type strain (Remacle, Duby et al. 2001; Cardol, Matagne 
et al. 2002).  
Most of the mutations located in the cob gene are deletions covering not only the coding 
sequence but also the left telomere, as for example dum11 that lacks the left end of the 
mitochondrial DNA including a part of the cob gene (Fig. 8A) (Remacle, Cardol et al. 2006). 
Whereas mutations in the cox1 and nd genes are usually frameshifts (Remacle, Duby et al. 2001) 
like for dum17 (Fig. 8A). In addition, another type of mutation was found: the mud2 mutation at 
codon 129 (Phe TTC → Leu CTC) of the cob gene. This mutation confers resistance to 
myxothiazol and mucidine, inhibitors of the complex III (Bennoun, Delosme et al. 1992). All the 
mitochondrial point mutants studied so far were found to be homoplasmic, i.e. they contain 
only mutated mitochondrial genomes. 
 
 
Figure 8 : Description of two mitochondrial mutants, dum11 and dum17. (A) dum11 lacks the left end of the mitochondrial DNA 
including part of the cob gene as shown and dum17 presents a frameshift mutation in nd6. (B) Under heterotrophic conditions, 
dum11 and dum17 show different phenotype; dum11 is unable to growth in the dark in the presence of acetate because of its 
complex III deficiency, and dum17 shows a reduced growth compared to the wild type strain due to the complex I deficiency.    
 
 
 
 
  
Figure 8 
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II.3. OTHER MITOCHONDRIAL DNA 
II.3 (1) MITOCHONDRIAL DNA IN PLANT  
 
(1) 1. STRUCTURE 
 Plant mitochondrial genomes are very large (220 – 2,000 kb) and often occur as 
complex pools of recombined molecules whose stoichiometry is tightly controlled by the 
nucleus. Unlike their mammalian and fungal counterparts, plant mitochondrial transcripts 
undergo complex post-transcriptional modifications such as editing and trans-splicing. 
 Two types of mitochondrial DNA are present in the embryophytes (land plants). The 
mitochondria of the three clades of bryophytes (liverworts, hornworts and mosses) possess 
circular genomes of around 105 – 185 kb resembling that of their green algal relatives like Chara 
and even the early-branching nongreen eukaryote, Reclinomonas americana (Li, Wang et al. 
2009). They are therefore considered to be of the ancestral type despite the acquisition of 
several additional features such as moderate size increase, intron gain and RNA editing, which 
are generally absent in algal genomes (Wang, Xue et al. 2009). On the contrary, the 
mitochondria of seed plants harbor much larger genomes, from 221 kb for the smallest 
mitochondrial genome sequenced to date (Handa 2003) to more than 2000 kb in the 
Cucurbitaceae family (Ward, Anderson et al. 1981). The size increase does not reflect an 
increase of the gene content but addition of non coding sequences such as introns, DNA repeat 
motifs and insertion of nuclear and chloroplast fragments (Knoop 2004). In addition seed plants 
possess a complex pool of frequently recombining molecules, the stoichiometry of which is 
controlled by nuclear genes (Abdelnoor, Yule et al. 2003; Arrieta-Montiel, Shedge et al. 2009).  
(1) 2. MUTATION AFFECTING PLANT MTDNA 
 Several significant seed plant mtDNA mutations were identified. Among them, some 
are found in subunits of the respiratory-chain complexes and are responsible for visible 
phenotypes such as the cytoplasmic male sterility in tobacco (Pla, Mathieu et al. 1995; 
Gutierres, Sabar et al. 1997; Pineau, Mathieu et al. 2005) or the nonchromosomal stripe 
phenotype in maize (Karpova and Newton 1999; Kubo and Newton 2008).   
II.3 (2) MITOCHONDRIAL DNA IN SACCHAROMYCES CEREVISIAE  
 
(2) 1. STRUCTURE OF  S. CEREVISIAE MITOCHONDRIAL GENOME   
The mitochondrial genome of Saccharomyces cerevisiae is a 85 779 bp circular molecule 
that includes a set of mitochondrion-specific tRNA genes, two rRNA genes and a very small set 
of genes encoding proteins involved in the electron-transport system (Foury, Roganti et al. 
1998). Genes contained in the mtDNA are those for cytochrome c oxidase subunit I, III and II 
(cox1, 2 and 3) , the ATP synthase subunits 6, 8 and 9 (atp6, atp8 and atp9), apocytochrome b 
(cytb), a ribosomal protein (var1), several intron-related open reading frames (ORFs) as well as 
the 9S RNA component of RNase P (de Zamaroczy and Bernardi 1986; Tzagoloff and Myers 
24 
 
1986). Thus the majority of the 500 – 800 proteins localized in the mitochondrion are encoded 
by the nuclear genome (Perocchi, Jensen et al. 2006).  
The multi-copy mitochondrial genome from S. cerevisiae is characterized by high A+T 
content. Its base composition is highly heterogeneous (Bernardi, Piperno et al. 1972) ; while the 
G+C content of the genes is approximately 30%, the intergenic spacers are composed of quasi-
pure A+T stretches of several hundreds of base pairs, interrupted by more than 150 G+C-rich 
clusters, ranging from 10 to 80 bp in length (de Zamaroczy and Bernardi 1986).  
Transcription of yeast mtDNA is polycistronic and is initiated at several sites 
characterized by the A/TTATAAGTA consensus sequence (Christianson and Rabinowitz 1983; 
Osinga, De Vries et al. 1984). All the genes are transcribed from the same strand, except the 
tRNAthr. In addition, the mitochondrial genome contains seven to eight replication origin-like 
(ori) elements.  
(2) 2. MUTATION AFFECTING S. CEREVISIAE MITOCHONDRIAL GENOME   
 An unusual and very useful feature of mitochondrial genetics in the yeast 
Saccharomyces cerevisiae is the occurrence of mutations, termed rho-, that block respiration by 
deleting large portions of wild-type (rho+) mtDNA (Dujon 1981). Rho- mutations may delete any 
segment of mtDNA, and in the limit case such mutations produce strains, termed rho0, whose 
mitochondria contain no mtDNA at all. DNA sequences retained in rho- strains are present as 
concatemers whose size roughly equals that of wild-type mtDNA. Genetic information encoded 
in rho- mtDNA can be expressed by crosses to appropriate rho+ strains, either after 
recombination with rho+ mtDNA (marker rescue) or in trans by selective maintenance of a 
heteroplasmic state. Because of these properties, the ability to manipulate the content of rho- 
mtDNA by genetic transformation is an enormous asset in the study of function and expression 
of yeast mitochondrial genes.  
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PART III. MITOCHONDRIAL TRANSFORMATION  
Nowadays, in vivo and stable mitochondrial transformation is only feasible in two 
unicellular organisms the yeast Saccharomyces cerevisiae (Fox, Sanford et al. 1988; Johnston, 
Anziano et al. 1988; Bonnefoy and Fox 2002) and the green alga Chlamydomonas (Remacle, 
Cardol et al. 2006). High efficiency transformation methods were developed (Johnston, Anziano 
et al. 1988; Remacle, Cardol et al. 2006) and respiratory deficient mutants serve as recipient 
strains for mt transformation.  
This part is dedicated to description of successes and defeats in mitochondrial 
transformation. More information concerning the mitochondrial transformation of the green 
alga Chlamydomonas reinhardtii and about alternative approaches for mitochondrial 
transformation are reviewed in Annex 2 (Remacle, Hamel et al. 2011).   
III.1. MTDNA TRANSFORMATION IN SACCHAROMYCES CEREVISIAE   
Biolistic (biological ballistic) process is used to deliver DNA into yeast cells to stably 
transform their mitochondria. A non reverting strain, which is respiratory deficient because of a 
deletion in the mitochondrial cox1 gene, could be bombarded with tungsten microprojectiles 
coated with DNA bearing sequences that could correct the cox1 deletion. Respiratory 
competent transformants were obtained in which the introduced cox1 DNA is integrated at the 
homologous site in the mitochondrial genome (Johnston, Anziano et al. 1988).  
In yeast, auxotrophic markers corresponding to nuclear genes encoding enzymes 
targeted to mitochondria are attractive for the development of a selection method. Indeed, 
expression of a synthetic ARG8 gene from the mitochondrial genome allows nuclear arg8 
mutants to grow without arginine (Steele, Butler et al. 1996). The Arg8 protein is normally 
imported into mitochondria from the cytoplasm, but also functions when synthesized within the 
organelle in the mitochondrial transformants. Thus, arginine prototrophy can become a 
phenotype dependent on mt gene expression.  
III.2. MTDNA TRANSFORMATION IN CHLAMYDOMONAS REINHARDTII  
In the first report of mitochondrial transformation in Chlamydomonas, a mutant (dum1) 
deleted for the left telomere and cob gene (1.5 kb deletion) was successfully transformed to 
respiratory competence with partially purified mt DNA from C. reinhardtii or C. smithii using a 
biolistic device (Randolph-Anderson, Boynton et al. 1993). C. reinhardtii and C. smithii are two 
interfertile species, which harbor identical mt genomes with the exception of a 1 kb group I 
intron located in the cob gene that is present in C. smithii but absent in C. reinhardtii (Boynton, 
Harris et al. 1987; Remacle, Bovie et al. 1990). Some years later, biolistics was again used 
successfully to transform the same recipient strain, with purified mtDNA or cloned mtDNA 
fragments (Yamasaki, Kurokawa et al. 2005). In both cases, the wild-type mt sequence of the 
transforming DNA had replaced the deleted genome in the transformants selected under 
heterotrophic conditions. Transformation efficiency was low (0.4 – 3 transformants/mg DNA). 
This precluded any genetic manipulation of the mt genome, since isolation of transformants 
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with the desired genotype usually requires the screening of many colonies, as this is also the 
case in Saccharomyces mitochondrial transformation (Bonnefoy and Fox 2007).  
Subsequently, biolistic transformation was optimized using cloned mtDNA or PCR 
fragments as transforming molecules (Remacle, Cardol et al. 2006). In this paper, the dum11 
mutant lacking 1.2 kb of the left part of the genome, previously described in (Dorthu, Remy et 
al. 1992), was transformed using a mtDNA fragment covering the deletion and the cob gene as 
donor DNA. Transformants were rescued after selection in the dark. Homologous recombination 
occurred between the introduced DNA and the endogenous mt genome (Remacle, Cardol et al. 
2006) and mt transformants were homoplasmic for the 15.8 kb wild-type genome. A high 
transformation efficiency was achieved (100 – 250 transformants/µg DNA) using linearized DNA 
for transformation.  
Interestingly, a strain lacking the cob gene and the left telomere could be rescued, 
although at a very low rate, when the transforming DNA is nearly completely devoid of the left 
telomere (Remacle, Cardol et al. 2006). This indicated that the right telomere can be copied to 
reconstruct the left telomere by recombination. But no information is known about this process.   
 Using the strategy described above, it was possible to introduce non-deleterious 
mutations and also loss-of-function molecular lesions in the mt genome. Myxothiazol-resistant 
transformants were generated by introducing the nucleotide substitution that is present in the 
cob gene of the strains displaying myxothiazol resistance (Remacle, Cardol et al. 2006). Similarly, 
an in-frame deletion of 23 codons was reconstructed in the nd4 gene with a frequency of one 
homoplasmic nd4 transformant among 90 transformants analyzed (Remacle, Cardol et al. 2006). 
During selection in the dark, recombination events resulted in the co-integration of the cob gene 
and the deletion in nd4 in some molecules of the mt genome despite the negative effect of the 
nd4 mutation on complex I assembly and activity as well as on whole cell respiration (Remacle, 
Cardol et al. 2006). These results open the way to reverse genetics in Chlamydomonas 
mitochondria and more specifically, to site-directed mutagenesis of mitochondrially encoded 
subunits of complex I (ND subunits). This is of special interest because the yeast S. cerevisiae, 
whose mt genome is also manipulated, lacks complex I. 
III.3. MTDNA TRANSFORMATION IN PLANT  
It is impossible to stably transform plant mitochondria and hence to manipulate mt gene 
expression. Few years ago, a candidate to plant mtDNA transformation was described as a 
promising system, the cucumber (Havey, Lilly et al. 2002). Despite several attempts, no 
successful transformation of mitochondria in cucumber or any plant system has been reported 
to date. The reasons for the failure are probably multiple: (1) the lack of a method to transform 
either microspores or pollen cells or the ovule for plants with maternal transmission of 
mitochondria; (2) the fact that plant mt genomes are extremely complex and unstable and can 
rapidly evolve via substoichiometric shifting due to recombination (Small, Isaac et al. 1987; 
Mackenzie 2007); (3) the lack of a selection that is maintained throughout the formation of the 
adult plant after zygote formation.  
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III.4. MTDNA TRANSFORMATION IN MAMMAL   
Small linear DNA fragments such as oligonucleotides (Vestweber and Schatz 1989) or 
double-stranded DNA (dsDNA) (Seibel, Trappe et al. 1995) can be transported into mitochondria  
(Chinnery, Taylor et al. 1999; Geromel, Cao et al. 2001; Flierl, Jackson et al. 2003). Much larger 
plasmid DNA molecules have also been introduced into isolated mammalian mitochondria by 
electroporation (Collombet, Wheeler et al. 1997) but the electroporation conditions used in 
these procedures appear to cause irreparable damage to the mitochondria that prevents their 
reincorporation back into mammalian cells (Y.G. Yoon, unpublished data). A study where an 
exogenous DNA could be introduced into the mitochondria of human cells using a process called 
‘protofection’, a system involving bacteria-to-mitochondria conjugation (Yoon and Koob 2005), 
was tried but revealed also not conclusive. Some successes were done in transferring in vitro 
mitochondria from a patient, suffering from mitochondrial pathology, into cultured mtDNA-less 
human cells (Chomyn, Meola et al. 1991; Hayashi, Ohta et al. 1991; Hayashi, Ohta et al. 1993). 
Moreover in vitro microinjections of viable mitochondria, isolated from human somatic cells 
were done in mice cells but these analysis did not get further (Irwin, Johnson et al. 1999; 
Takeda, Tasai et al. 2005). So far, in vivo direct engineering of the mtDNA genome in mammalian 
mitochondria is still impossible.  
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PART IV. CHLOROPLAST, THE GREEN ENERGY POWERHOUSE 
Plastids originated between 1.6 and 0.6 billion years ago as a result of a symbiotic 
association between a cyanobacterium and a mitochondriate eukaryote. This endosymbiotic 
event generated the green and red algal lineages, which subsequently spread their chloroplasts 
when these new photosynthetic eukaryotes were, in their turn, engulfed by nonphotosynthetic 
eukaryotes (between, 1.2 and 0.55 billion years ago) generating more algal divisions (Falconet 
2011). It is widely accepted that the ancestors of modern land plants (embryophytes) evolved 
from green algae, or more specifically, from a small but diverse group of green algae known as 
the streptophyte algae (charophycean algae)(Wodniok, Brinkmann et al. 2011).  
IV.1. HISTORY  
The first observations of chloroplasts were done in the seventeenth century by 
Nehemiah Grew in England and Anthony van Leeuwenhoek in the Netherlands but it is only in 
the mid nineteenth century that two French microscopists, Jean Baptiste Arthur Gris (1857) and 
August Adolphe Lucien Trécul (1858), published drawings of chloroplasts and termed them 
vesicles. The term plastid was introduced later by Schimper (1883) defining a category of 
organelles of the plant cell. Schimper also classified plastids into different group (chloroplasts, 
leucoplasts and chromoplasts) and suggested that the latter arose from the transformation of 
the former. Concomitantly with the observation of chloroplasts, the concept of plastid 
continuity, stipulation that plastids do not arise de novo but from preexisting plastids, was 
announced. This concept was proposed after extensive studies on the development of plastids, 
first observed in algae (Nageli 1846; Schmitz 1883) and then extended to higher plants (Meyer 
1883; Schimper 1883). But, undoubtedly, it was a Russian botanist, Constantin Mereschkowsky, 
who published at the beginning of the twentieth century the more convincing demonstration of 
the endosymbiotic origin of chloroplasts. His demonstration was based upon three lines of 
evidence known at the time as: (1) the known principle of symbiosis, already stated to designate 
coexistence of distinct organisms; (2) the observations that chloroplast divided and the notion 
of plastid continuity; and (3) the evidence of the resemblance between cyanobacteria and 
plastids.  
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IV.2. STRUCTURE OF PLASTIDS  
Chloroplast is the organelle where photosynthesis occurs in photosynthetic eukaryotes. 
In the green lineage, plastids have two envelope membranes (Fig. 9). The inner membrane 
defines an aqueus matrix, called the stroma, containing the Calvin cycle enzymes, responsible 
for CO2 fixation. A reticulate arrangement of membranes, the thylakoids, is present in the 
stroma (Fig. 9).  The thylakoids contain the enzymes responsible for the light reactions of 
photosynthesis. Thylakoids become appressed in certain region, i.e. they come close together 
with a gap between membranes of less than 2 nm (Fig. 9). Stacks of appressed membranes may 
occur with up to five layers in a stack, the grana (granum in Fig. 9).  
 
 
 
Figure 9 : Progresses made in microscopy, as in 
transmission electron microscopy (TEM), allows 
distinguishing properly the structure present in 
chloroplasts : the double layer membrane (outer and 
inner), the empty space called stroma, thylakoid  
membranes and the granum.  (Cummings 2006) 
 
IV.3. DISCOVERY OF CHLOROPLAST DNA, CPDNA  
In 1951 (Chiba 1951), it was first suggested that chloroplasts from the moss Selaginella 
and from two flowering plant species contained DNA. Numerous related reports appeared later 
in the late 1950s and early 1960s (reviewed (Sager and Schlanger 1976). Ris and Plaut (1962) 
demonstrated cytologically the presence of DNA in chloroplasts of the green alga, 
Chlamydomonas. The following year, Ruth Sager and Masahiro R. Ishida (1963) (Pardee 2001) 
provided strong evidence for the presence of unique DNA in chloroplasts from Chlamydomonas. 
They developed a method which allowed for the isolation of relatively intact chloroplasts 
from the alga and subsequently found an enriched satellite DNA with a buoyant density of 1,702 
gm/cm3 and GC content of 39.3%, which could be distinguished from nuclear DNA. Similar 
results were reported from other laboratories during that same year (Chun, Vaughan et al. 
1963), and thus by the end of 1963 the presence of chloroplast DNA was widely acknowledged. 
  
Figure 9 :  
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IV.4. CHLAMYDOMONAS REINHARDTII CHLOROPLAST GENOME STRUCTURE AND 
SEQUENCE  
The complete C. reinhardtii chloroplast genome has 203828 bp, 99 genes of known or 
presumed function and 8 expressed open reading frames (ORFs).The G+C content is 35% which 
is similar to the original prediction of Sager and Ishida (1963). The typical structure of 
chloroplast genomes in plants and algae, including Chlamydomonas, is quadripartite with two 
regions of a single-copy DNA and two large inverted repeat (IRs) (Palmer 1991; Simpson and 
Stern 2002; Pombert, Otis et al. 2005; Pombert, Lemieux et al. 2006). The large single-copy 
region (LSC) and small single-copy regions (SSC) are similar in size, 81307 bp and 78088, 
respectively. The inverted repeats are identical and each contains 22211 bp, including a copy of 
psbA, the five rRNA genes, and two tRNA genes (Maul, Lilly et al. 2002).  
IV.5. CHLOROPLAST DNA IN LAND PLANT  
The standard depiction of the chloroplast chromosome is a genome-sized circular DNA 
molecule. For most plants, restriction fragment mapping shows the chloroplast genome divided 
into large (LSC) and small (SSC) single copy regions separated by inverted repeat sequences (IRA 
and IRB) (Heinhorst and Cannon 1993; Kunnimalaiyaan and Nielsen 1997) (like in 
Chlamydomonas). Mapping further predicts two equimolar populations of circular molecules 
differing only in the relative orientation (inversion) of the single copy regions. Intramolecular 
recombination (“flipping”) between IRA and IRB is thought to generate the two isomeric circular 
forms (Palmer 1983; Palmer 1985). The total length of the cpDNA ranges from 120 to 160 kb in 
higher plants (Sugiura 1995). Since they have lost most of the IR regions, conifers and some 
legumes are exceptions regarding this phenomenon (Tsudzuki, Nakashima et al. 1992). 
Against this first idea, another study reported that the cpDNA is present in different 
topological forms (Oldenburg and Bendich 2004). The most cpDNA from maize was found in 
linear and multi-genomic complex branched forms, rather than circles. The ends of the linear 
molecules are not random, as expected from broken circles, and are near putative origins of 
replication in both IRA and IRB. Instead of flipping, inversion of single copy regions may occur 
during replication. The complex forms may arise by a recombination-dependent mechanism of 
replication.  
The complete sequences of the plastid genomes of many plants have been determined, 
and cover the major lineages, including monocot and dicot plants, gymnosperms, psilotophytes, 
and bryophytes. Comparative studies revealed that chloroplast genomes of higher plants are 
well conserved regarding gene content, gene order, and general structure (Palmer 1991).  
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PART V. CHLOROPLAST TRANSFORMATION  
The advantages of chloroplast genetic engineering include high-level transgene 
expression due to multiple chloroplast genomes per chloroplast and many chloroplasts per cell 
(De Cosa, Moar et al. 2001), the feasibility of expressing multiple proteins from polycistronic 
mRNAs, and gene containment through the lack of pollen transmission (Bock, Hermann et al. 
1996; Maliga 2002; Kittiwongwattana, Lutz et al. 2007), the avoidance of gene silencing 
(Dhingra, Portis et al. 2004), undesirable foreign DNA (Daniell, Chebolu et al. 2005), or position 
effect (Daniell and Dhingra 2002) and pleiotropic effects (Lee, Takei et al. 2003) due to position-
specific insertion of the transgene. 
V.1. HISTORY  
An Agrobacterium mediated method was firstly used for plastid transformation (Block, 
Schell et al. 1985) but in 1988, Boynton et al. could permanently restore the photosynthetic 
capacity of three mutants of the chloroplast atpB gene of Chlamydomonas reinhardtii by 
bombarding cells with high-velocity tungsten microprojectiles that were coated with cloned 
chloroplast DNA carrying the wild-type gene (Boynton, Gillham et al. 1988). Most of successful 
chloroplast transformations were achieved by this method due to the higher transformation 
efficiency and the simplicity of the operation. 
V.2. TRANSFORMABLE PLANT ORGANISMS  
After the chloroplast transformation in Chlamydomonas reinhardtii (Boynton, Gillham et 
al. 1988), the first stable plastid transformation was established soon after in Nicotiana tabacum 
(Daniell, Vivekananda et al. 1990; Svab, Harper et al. 1990). Up to date, plastid transformation 
has extended to many other higher plants, such as Arabidopsis (Sikdar, Serino et al. 1998), rape 
(Hou, Zhou et al. 2003), Lesquerella (Skarjinskaia, Svab et al. 2003), rice (Lee, Kang et al. 2006), 
potato (Sidorov, Kasten et al. 1999), lettuce (Lelivelt, McCabe et al. 2005), soybean 
(Dufourmantel, Pelissier et al. 2004), cotton (Kumar, Dhingra et al. 2004), carrot (Kumar, 
Dhingra et al. 2004), tomato (Ruf, Hermann et al. 2001) and poplar (Okumura, Sawada et al. 
2006). However, plastid transformation is routine only in tobacco and the efficiency of 
transformation is much higher in tobacco than in other plants (Maliga 2004). 
V.3. SELECTION FOR CHLOROPLASTIC TRANSFORMATION  
Since cpDNA is present in many copies, selectable marker genes are critically important 
to achieve uniform transformation of all genome copies during an enrichment process that 
involves gradual sorting out non-transformed plastids on a selective medium (Maliga 2004; 
Kittiwongwattana, Lutz et al. 2007).  
The first selection marker gene used in chloroplast transformation was the 
spectinomycin resistance encoded by the 16S rRNA (rrn16) gene (Svab, Harper et al. 1990). 
Transgenic lines were selected by spectinomycin resistance and the efficiency was low. 
Subsequently, the aadA gene encoding aminoglycoside 3′-adenylyltransferase was used as a 
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selection marker gene (Goldschmidt-Clermont 1991; Svab and Maliga 1993). Transformation 
with aadA gene dramatically improved the recovery of plastid transformants to a rate of, on 
average, about one transplastomic line in a bombarded leaf sample (Svab and Maliga 1993). 
Another dramatic improvement in plastid transformation efficiency was obtained with the 
bombardment of leaves with the vector that carries the new neo gene (pAAK201) (Kuroda and 
Maliga 2001). The bacterial bar gene, encoding phosphinothricin acetyltransferase, has also 
been tested as a marker gene, but it was not good enough (Lutz, Knapp et al. 2001). Another 
marker gene is the betaine aldehyde dehydrogenase (BADH) gene which confers resistance to 
betaine aldehyde. Chloroplast transformation efficiency was 25-fold higher with betaine 
aldehyde selection than with spectinomycin in tobacco (Daniell, Muthukumar et al. 2001).  
 Nowadays, the use of antibiotic resistances as selectable markers causes bioethics 
questions. What could be the impact of such resistances on human health  or biodiversity? More 
than ever, alternative methods involving other selection markers have to be developed.    
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PART VI. NEXT-GENERATION GENOME SEQUENCING, THE ILLUMINA 
SEQUENCING   
The impact of genome sequencing on everyday life is getting more and more obvious. 
The use of DNA-based information could be used in routine medical checkup for the prediction 
of disease, or to explore the genetic diversity in a given population, or to study the diversity in 
birds or to search for new drought resistant traits in agricultural crops. It was thus a big 
challenge to make it affordable. In fact, the Human Genome Sequencing Consortium generated 
3 Gb at the cost of approximately 3 billion $ and took 13 years. But the cost of the next-
generation of determining an individual genome sequence would fall in the next years to a price 
of around 1,000 $ (Mardis 2006). 
Illumina sequencing technology leverages clonal array formation and proprietary 
reversible terminator technology for rapid and accurate large-scale sequencing. The innovative 
and flexible sequencing system enables a broad array of applications in genomics, 
transcriptomics, and epigenomics. 
VI.1. SAMPLE PREPARATION AND SEQUENCING PROCEDURE ((JANITZ 2008) AND 
WWW.ILLUMINA.COM)    
The first step of this sequencing method is the preparation of genomic DNA sample. The 
genomic DNA is randomly fragmented by nebulization or sonication.  This procedure requires 
approximately 100 ng of DNA and takes more or less one day. After that DNA fragment are blunt 
ended by polymerase and exonuclease activity (Fig. 10A) followed by phosphorylation (B) and 
addition of an adenosine overhang (C). Illumina sequencing adapters are then ligated to both 
ends of the DNA fragments (D). These DNA fragments templates are immobilized on a flow cell 
surface, extended and denaturated (Fig. 10E, F and G). This flow cell is made in silicate and 
designed to present the DNA in a manner that facilitates access to enzymes while ensuring high 
stability of surface bound template. The next step is a solid-phase bridge amplification (Fig. 10H, 
I) initiated by unlabelled nucleotides and enzyme.  At this moment, the enzyme has 
incorporated nucleotides to build double-stranded bridges on the solid-phase substrate. The 
following step leads to the denaturation of the double-stranded brigdes (Fig. 10 J), the reverse 
strands cleavage (arrow in Fig. 10K) and the results is the single-stranded templates anchored to 
the substrate (Fig. 10L). 3’ ends are then blocked and the strands are hybridized to sequencing 
primers (Fig. 10M). The first sequencing cycle begins by adding four labeled reversible 
terminators, primers, and DNA polymerase, this technology is called sequencing-by-synthesis 
(SBS). The major advantage is that the sequencing of the tens millions of clusters on the flow cell 
surface can be done in parallel.  
During each sequencing cycle, the DNA polymerase incorporates to the nucleic acid 
chain the single labeled deoxynucleoside triphosphate (dNTP) (Fig. 10N). The nucleotide label 
serves as a reversible terminator for polymerization. After each dNTP incorporation, the 
fluorescent dye is imaged to identify the base (Fig. 10O). After imaging, the fluorescent tag is 
then enzymatically cleaved (Fig. 10P) to allow incorporation of the next nucleotide. Since all four 
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reversible terminator-bound dNTPs (A, C, T, G) are present as single, separate molecules, natural 
competition minimizes incorporation bias. Base calls are made directly from signal intensity 
measurements during each cycle (Fig. 10Q), which greatly reduces raw error rates compared to 
other technologies. The end result is highly accurate base-by-base sequencing that eliminates 
sequence-context specific errors, enabling robust base calling across the genome.  
  
Figure 10 : The sequencing-by-synthesis process used in illumina sequencing technology (Janitz 
2008) 
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PART VII. OBJECTIVES 
VII.1. NUCLEAR TRANSFORMATION  
VII.1 (1) ISOLATION AND CHARACTERIZATION OF NUCLEAR COMPLEX I MUTANTS IN THE 
UNICELLULAR GREEN ALGA CHLAMYDOMONAS  
Respiratory complex I is a very large multiprotein complex found in most energy 
converting membranes of bacteria and eukaryotes. The lack of a model system with facile 
genetics has limited the molecular dissection of complex I in particular in order to identify novel 
assembly factors.  
The first objective of my thesis was thus to identify new assembly factors by the 
development of a forward genetic screen of Chlamydomonas reinhardtii nuclear complex I 
mutants.  
This objective was realized in collaboration with Prof. Patrice Hamel (Ohio State 
University, Columbus, Ohio, USA). 
VII.2. ORGANELLE TRANSFORMATION  
VII.2 (1) RECONSTRUCTION OF A HUMAN MITOCHONDRIAL COMPLEX I MUTATION IN THE 
UNICELLULAR GREEN ALGA CHLAMYDOMONAS 
The pathogenicity of a given human mitochondrial mutation can be difficult to analyze 
because the mitochondrial genome harbors large numbers of polymorphic base changes that 
have no pathogenic significance, and because of the heteroplamic status of some human 
mitochondrial mutations. The only model organism in which mitochondrial genome 
transformation is feasible is the yeast, Saccharomyces cerevisiae but mutations affecting 
complex I mitochondrial subunits cannot be studied because the yeast lacks complex I.  
The second objective of my thesis was thus to use the unicellular green alga 
Chlamydomonas as a system to study heteroplasmic and uncharacterized human mitochondrial 
mutations. Chlamydomonas should be suitable for this because (1) respiratory-deficient 
mutants are viable and mitochondrial mutations are found in the homoplasmic state (Remacle, 
Baurain et al. 2001; Remacle, Duby et al. 2001), (2) transformation of the mitochondrial genome 
is feasible (Remacle, Cardol et al. 2006), (3) Chlamydomonas complex I is close to that of 
humans (Cardol, Vanrobaeys et al. 2004; Cardol 2011).  
We decide to introduce and characterize a Leu157Pro substitution in the 
Chlamydomonas ND4 subunit of complex I, proposed to be responsible in humans for CPEO 
(Chronic Progressive External Ophthalmoplegia Syndrome).  
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VII.2 (2) ROLE OF THE LEFT TERMINAL REPEAT OF THE CHLAMYDOMONAS MITOCHONDRIAL 
GENOME IN TRANSFORMATION AND REPLICATION  
A role of the left extremity of the mitochondrial genome for mtDNA transformation 
efficiency was suggested by (Remacle, Cardol et al. 2006). Indeed, if only 28 bp of the 500 bp 
telomeric end were kept for mitochondrial transformation, the transformation rate dropped 
drastically. The presence of the entire left telomere in the donor DNA is thus essential to reach a 
high level of transformation. But which portion of the left extremity is essential remained 
unsolved.  
The third objective of my thesis was to sharp the previous analysis in order to identify 
the most important portion of the left extremity in mt transformation, and to identify by 
bioinformatics analysis motifs that could be involved in replication. 
VII.2 (3) DEVELOPMENT OF A NEW SELECTABLE MARKER FOR CHLOROPLAST TRANSFORMATION 
IN CHLAMYDOMONAS 
More than ever, alternative selectable markers not based on antibiotic resistances have 
to be developed for avoiding problem of bioethics.   
In the green alga Chlamydomonas, mutations in the ARG9 nuclear locus lead to arginine 
auxotrophy because of a deficiency in N-acetyl ornithine aminotransferase, an enzyme involved 
in the biosynthesis of arginine.  
A side objective of my thesis was to contribute to the development of a new selectable 
marker for the chloroplast, based on the restoration of the arginine prototrophy.  
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 Chapter 2: Results 
 
 
 
 
 Nuclear transformation  
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PART I. ISOLATION AND CHARACTERIZATION OF COMPLEX I MUTANTS IN 
THE UNICELLULAR GREEN ALGA CHLAMYDOMONAS (BARBIERI, LAROSA 
ET AL. 2011) 
Mitochondrial complex I is the largest multimeric enzyme of the electron transport 
chain. It is composed of a hydrophilic peripheral arm protruding into the mitochondrial matrix 
and a membrane arm (reviewed in (Remacle, Hamel et al. 2012 )). Previously the lack of a model 
system with facile genetics has limited the molecular dissection of complex I (reviewed in 
(Remacle, Hamel et al. 2012 )). We suggest in 2011 in collaboration with Prof. Hamel (Ohio State 
University - USA) to use Chlamydomonas as an experimental system to screen for complex I 
defects via forward genetics (Barbieri, Larosa et al. 2011). For that purpose, an insertional library 
was built that was subsequently screened for complex I mutants. I’ve contributed to the 
construction of the insertion mutant library (generation of 10000 out of 50000 transformants) 
using a hygromycin (an aminoglycoside type antibiotic) resistance cassette and to the screening 
of these 10000 transformants for complex I mutants (Barbieri, Larosa et al. 2011). Complex I 
mutant screening was based on the fact that these mutants present a reduced growth in 
heterotrophic conditions (dark + acetate as carbon source). I have also characterized 
biochemically 6 complex I mutants and compared them to amc2 mutant previously described 
(Remacle, Baurain et al. 2001). Complex I mutants were named amc1 to 7 (for assembly of 
mitochondrial complex I). These mutants displayed reduced or no complex I activity. Blue native 
(BN)-PAGE and immunoblot analyses revealed that amc3, and -4 accumulated reduced levels of 
the complex I holoenzyme (950 kDa) while all other amc mutants amc1, -2, -5, -7 failed to 
accumulate a mature complex. Instead, a 700 kDa subcomplex retaining NADH dehydrogenase 
activity was observed. Genetic analyses established that amc5 and amc7 are alleles of the same 
locus while amc1–4 and amc6 defined distinct complementation groups. The locus defined by 
the amc5 and amc7 alleles corresponds to the NUOB10 gene, encoding PDSW, a subunit of the 
membrane arm of complex I.  
Loci defined by the others alleles are not yet identified because the mutations were not 
tagged with the resistance cassette. Other techniques to identify mutation involving complex I 
deficiencies were planned and discussed in PART II. In fact nowadays performing whole-genome 
sequencing becomes easy and affordable using Illumina's sequencing technology. Like this, in 
collaboration Prof. Denis Baurain (University of Liège), the entire genome of amc4 and amc8 (a 
complex I mutant coming from another insertion library) mutants were sequenced. I’m currently 
comparing their genomes and trying to localize the gene involved in the complex I deficiency. 
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ABSTRACT
Mitochondrial complex I is the largest multimeric enzyme of the respiratory chain. The lack of a model
system with facile genetics has limited the molecular dissection of complex I assembly. Using Chlamydomonas
reinhardtii as an experimental system to screen for complex I defects, we isolated, via forward genetics,
amc1–7 nuclear mutants (for assembly of mitochondrial complex I) displaying reduced or no complex I
activity. Blue native (BN)-PAGE and immunoblot analyses revealed that amc3 and amc4 accumulate reduced
levels of the complex I holoenzyme (950 kDa) while all other amc mutants fail to accumulate a mature
complex. In amc1, -2, -5–7, the detection of a 700 kDa subcomplex retaining NADH dehydrogenase activity
indicates an arrest in the assembly process. Genetic analyses established that amc5 and amc7 are alleles of
the same locus while amc1–4 and amc6 deﬁne distinct complementation groups. The locus deﬁned by the
amc5 and amc7 alleles corresponds to the NUOB10 gene, encoding PDSW, a subunit of the membrane arm
of complex I. This is the ﬁrst report of a forward genetic screen yielding the isolation of complex I mutants.
This work illustrates the potential of using Chlamydomonas as a genetically tractable organism to decipher
complex I manufacture.
MULTIMERIC respiratory complexes I, III, and IVin the mitochondrial inner membrane generate
the proton motive force that is critical for ATP produc-
tion. Complex I, the largest respiratory complex, is
a NADH-ubiquinone oxidoreductase with a hydrophilic
peripheral arm protruding into the mitochondrial ma-
trix and a membrane arm (Sazanov and Hinchliffe
2006; Efremov et al. 2010; Hunte et al. 2010). It is
known that the assembly of multimeric enzymes is as-
sisted by factors absent from the mature enzyme but
nevertheless essential in promoting its assembly into
an active form. In humans, complex I dysfunction is
the cause of severe diseases (Distelmaier et al. 2009).
Since only 40% of the nuclear mutations in complex I-
linked diseases occur in structural subunits of complex
I, it is generally accepted that the other 60% represent
defects in factors recruited to assemble or regulate the
complex (Loeffen et al. 2000; Thorburn 2004).
In recent years, the use of model organisms has
contributed to the identiﬁcation of factors involved in
the assembly of respiratory complexes. Most of these
studies have been carried out in the model organism
Saccharomyces cerevisiae, which has a broad spectrum
of genetic and molecular tools facilitating research
(Barrientos 2003). However, given that S. cerevisiae
and its related species have lost complex I subunits
(Gray et al. 2001), they cannot be used as a model for
the study of complex I assembly. Instead, the lack of
complex I in S. cerevisiae and other eukaryotes has been
instrumental in revealing candidate complex I assembly
factors through subtractive phylogenetic analyses. In con-
junction with mitochondrial proteomic data from com-
plex I-bearing organisms, these analyses were recently
used to identify a number of candidate assembly factors
(Pagliarini et al. 2008). Three of these factors,
C8ORF38, C20ORF7, and FOXRED1, were found to
be mutated in complex I-deﬁcient patients (Pagliarini
et al. 2008; Sugiana et al. 2008; Fassone et al. 2010). A
limitation of subtractive phylogenetics is that assembly
factors are assumed to have been systematically lost from
organisms lacking complex I, hence excluding the possi-
bility of ﬁnding conserved genes that have acquired dual
or novel function. Therefore, there is still a need for a ge-
netic approach to discover loci controlling complex I as-
sembly on the basis of loss-of-function phenotypes.
Fungi, animals, and vascular plants have been used
extensively as experimental systems for the study of
complex I defects (Remacle et al. 2008). Although such
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models were invaluable in documenting the impacts of
speciﬁc mutations in complex I function, they were not
developed for the isolation of complex I mutants
through forward genetics.
Chlamydomonas reinhardtii, a unicellular green alga, is a
very promising experimental system to address the ques-
tion of complex I assembly (Remacle et al. 2008). It is an
ideal organism to study mitochondrial biogenesis be-
cause complex I-less mutants are viable due to the oper-
ation of alternative NADH dehydrogenases (Remacle
et al. 2001a). Moreover, complex I-deﬁcient mutants
can be maintained in phototrophic (light) or mixotro-
phic (light1 carbon source) conditions because they are
not defective in photosynthesis (Cardol et al. 2003).
This provides an advantage to screen for complex I mu-
tants, as they display robust growth under mixotrophic/
phototrophic conditions but slow growth under hetero-
trophic conditions (dark 1 carbon source) (Remacle
et al. 2001a; Cardol et al. 2002). In contrast, complex
III or complex IV mutants display arrested growth in the
dark (dark dier or dk). That a complex I mutant retains
two respiratory complexes (III and IV) out of the three is
believed to account for the “slow” growth phenotype.
Indeed, in a complex I mutant, complexes III and IV
still contribute to the formation of the proton electro-
chemical potential, and thus to ATP formation. How-
ever, in a complex III or complex IV mutant, the
contribution of complex I to the proton gradient is as-
sumed to be insufﬁcient to sustain growth in the dark
(Wikström 1984; Galkin et al. 2006). Several mutations
in complex I subunits encoded by the mitochondrial
genome and one nuclear mutation (amc2, assembly of
mitochondrial complex I, not yet characterized molecularly)
have been described in Chlamydomonas (Remacle et al.
2001a). Here, we used a mutagenesis approach to search
for additional amc mutants of nuclear origin. Six amc
mutants, deﬁning ﬁve loci, were isolated. The amc mu-
tants are affected to different extents in complex I activ-
ity and most of them result in the accumulation of
subcomplexes, an indication that the assembly process
Figure 1.—Six novel sid mutants display a de-
fect in complex I activity. (A) Tenfold dilution
series of amc1–7 and wild-type (wt) cells were
plated on acetate-containing medium and incu-
bated 3 days in the light or 5 days in the dark.
(B) Complex I-speciﬁc activity (nmol NADH
reduced/min/mg of protein) is indicated as averages
of 10 independent measurements. (C) BN-PAGE
and in-gel NBT staining of NADH dehydrogenase
activity. The black and gray arrowheads indicate
the position of the mature 950-kDa complex I
and the 700-kDa subcomplex, respectively. The
purple bands indicate staining for NADH oxi-
dase activity in complex I and subcomplexes. Note
that complex I is often resolved into two or more
purple bands of high molecular weight. The iden-
tity of such bands is unclear but they do not cor-
respond to the supercomplex I 1 III2 (Cardol
et al. 2008). The green bands correspond to pho-
tosystems I and II and their respective light har-
vesting complexes of the chloroplast (Rexroth
et al. 2003; Cardol et al. 2006). (D) NADH:
ferricyanide oxidoreductase activity (nmol
K3[Fe (CN)6] reduced/min/mg of protein). The
results represent the average of three independent
determinations. (B and D) Error bars indicate stan-
dard error (SE).
TABLE 1
Complex I-dependent oxygen consumption of amc
and wild-type strains
Respiration
(mmol O2 h21 mg21 of chlorophyll)
Strain 2rotenone 1rotenone
wt 61.0 6 2.0 42.0 6 4.0
amc1 44.2 6 3.2 39.8 6 5.7
amc2 42.7 6 0.8 41.0 6 5.4
amc3 44.6 6 5.0 40.1 6 6.8
amc4 43.9 6 5.3 43.7 6 7.8
amc5 37.0 6 4.2 33.4 6 5.9
amc6 36.2 6 4.6 34.4 6 3.1
Wild-type and amc strains representative of the six different
AMC loci were grown mixotrophically (TAP 1 arginine,
light). Oxygen consumption was measured in the dark, with
or without the addition of 100 mM rotenone to speciﬁcally
inhibit complex I. Values represent the average of three in-
dependent measurements and 6 indicates standard error.
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of the membrane arm is compromised. In amc5 and
amc7, the identiﬁcation of molecular lesions in the
NUOB10 gene encoding PDSW, a subunit of the mem-
brane arm, validates our mutant screen strategy. This
illustrates the potential of Chlamydomonas as an exper-
imental model system to dissect the molecular basis of
complex I assembly.
MATERIALS AND METHODS
Strains and culture conditions: Strains were grown at 22–25
in Tris-acetate-phosphate (TAP), arginine-supplemented TAP
liquid, or solid medium (Harris 1989) under continuous light
(50 mEm2sec21) as described in Howe and Merchant
(1992). Wild-type (wt) strains 3A1 and 4C2 were used for trans-
formation (J. D. Rochaix, University of Geneva, Switzerland)
and strains 137c1 and 137c2 were used for backcrosses. Strain
dn26 169 (mt2) and a mt1 derivative, renamed here amc2, were
used for crosses. Genetic analyses were performed as in Harris
(1989).
Insertional mutagenesis and identiﬁcation of the amc mutants:
3A1 (mt1 arg7-8) or 4C2 (mt2 arg7-8) cells were electroporated
with 100 ng of either a hygromycin B (iHyg) or paromomycin
(iPm) resistance cassette as in Shimogawara et al. (1998). The
iHyg and iPm cassettes were ampliﬁed by PCR from the pHyg3
(Berthold et al. 2002) or pSL18 (Depège et al. 2003) plasmids,
respectively. Oligonucleotides Aph7-F (59-TCGATATCAAGCT
Figure 3.—Effects of the amc mutations on
other respiratory complexes. (A) Complex II ac-
tivity (succinate:2,6-dichlorophenolindophenol
(DCIP) oxidoreductase). Three independent
determinations were averaged and activities are
expressed as nmol DCIP reduced/min/mg of
protein. (B) Complex III activity (decylubiquinol:
cytochrome c oxidoreductase). Averages from
three independent measurements are shown in
nmol of cytochrome c reduced/min/mg of pro-
tein. (C) Complexes II 1 III combined activities
(succinate:cytochrome c oxidoreductase) of 10 in-
dependent determinations (nmol of cytochrome c
reduced/min/mg of protein). dum11 is a complex
III mutant (Dorthu et al. 1992). (D) Complex IV
activity (cytochrome c oxidase). dum18 is a complex
IV mutant (Remacle et al. 2001b). Average activi-
ties of 10 independent determinations are
expressed in nmol cytochrome c oxidized/min/
mg of protein. Error bars indicate SE.
Figure 2.—The amc mutants are deﬁcient in complex I assembly. (A and B) Immunoblot analyses of membrane fractions,
separated by BN-PAGE, using anti-49 kDa (A) and anti-51 kDa (B). A total of 150 mg of proteins was loaded per lane. The ﬁgures
show the most representative blots of three independent experiments. The solid and shaded arrowheads indicate the position of
mature complex I and the 700-kDa subcomplex, respectively. Equal loading was tested by Coomassie blue staining (not shown) and
the presence of a nonspeciﬁc band revealed by the anti–49-kDa antiserum (Figure S2B for an example). (C) Membrane fractions
were separated by SDS–PAGE and immunoblot analyses were performed using polyclonal antibodies against subunit-speciﬁc
peptides. The subunits are 51 kDa, TYKY, and 49 kDa. A total of 10 mg of total protein per lane was loaded. Antibody speciﬁcity
was evaluated by peptide competition assays (not shown). Only the top band is speciﬁc for the 49-kDa subunit. Plastid cytochrome
f was used as a loading control. The results are representative from at least three independent membrane extractions.
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TCTTTCTTGC-39) and Aph7-R (59-AAGCTTCCATGGGAT
GACG-39) were used for ampliﬁcation of the iHyg cassette.
Aph8-F2 (59-TCAGGCAGACGGGCAGGTG-39) and Aph8-R
(59-TCAGGCAGACGGGCAGGTG-39) were used to amplify
the iPm cassette. Transformants were selected on TAP 1 ar-
ginine solid media with 25 mg/ml of hygromycin B or paro-
momycin in the light. After a 7- to 10-day incubation under
light, transformants were transferred individually to 96-well
plates and grown in selective liquid media. Individual colonies
were replica plated on solid TAP 1 arginine medium and
incubated in the dark and in the light for 7 days before
scoring.
Identiﬁcation of ﬂanking sequences by thermal asymmetric
interlaced-PCR: Ampliﬁcation of insertion-linked sequence by
thermal asymmetric interlaced (TAIL)-PCR was as described in
Dent et al. (2005). Four different degenerate primers, AD1 and
AD2 (Liu et al. 1995), RMD227 and RMD228 (Dent et al.
2005), were tested. iPm-speciﬁc primers were PmR1 (59-GAC
CCCGCAGTGCACGCAAC-39), PmR2 (59-GCTTGAGACAGC
GACAGAGGAGCC-39), and PmR3 (59-GCAAGTCAAATCTGC
AAGCACG-39) for the primary, secondary, and tertiary reactions,
respectively. The following NUOB10-speciﬁc primers were used:
PDSW-1F (59-CACCTGGTGCACATTGCTGTA-39), PDSW-2R
(59-TTCATGCTTGCCCGAGAAG-39), PDSW-5F (59-GACCAA
GGGCTTTCTGACTG-39), PDSW-7F (59-AGCCTCAGGCAT
ATTGCGC-39), PDSW-6R (59-ATCGCACATGACGGCAG-39),
PDSW-8R (59-GTAGATGAAGCCCACGTCG-39), PDSW-9F
(59-GTCATGAAGCGCCTGCAGG-39), PDSW-10R (59-GGAAC
TGGGTAAGGTTCTAAGC-39), PDSW-11F (59-CACTGCCTGA
AAGCCTGCC-39), and PDSW-12R (59-GAGGAGAGCAGTGGC
ATCGTG-39).
Protein extraction, SDS–PAGE, and immunoblot analyses:
Total protein was isolated from 2-day-old light-grown plates using
the freeze/thaw method (Howe and Merchant 1992). SDS–
PAGE was performed using standard protocols (Sambrook
et al. 1989).
Measurement of respiratory enzyme activities: Respiratory
activities were measured as described previously (Remacle
et al. 2001a, 2004; Cardol et al. 2002) using partially puriﬁed
membranes extracted from 2- to 3-day-old cultures.
Antibody production: Protein A puriﬁed polyclonal anti-
bodies directed against complex I subunit-speciﬁc peptides
were custom synthesized in rabbits by GeneScript (Piscataway,
NJ) using the following peptide antigens: NUO7 (49 kDa),
CGIDWDLRKTQPYDA; NUO6 (51 kDa), SLEGKQGKPRLKPPC;
NUO8 (TYKY), YASDWENDPTFKRTC. To assess antibody spec-
iﬁcity, protein extracts were competed with the peptides used to
generate the polyclonal antibodies (Howe andMerchant 1992).
For NUO7 (49 kDa), only the upper band detected with the
antiserum is speciﬁc.
BN-PAGE and in-gel activity: Separation of protein com-
plexes was done by BN-PAGE (Schägger and Von Jagow
1991). Detection of in-gel NADH dehydrogenase activity was
performed as in Rasmusson and Møller (1991).
RESULTS
Identiﬁcation of complex I-deﬁcient (amc) mutants
via insertional mutagenesis: Only one nuclear mutation
(amc2) resulting in a complex I defect has been pre-
viously described in Chlamydomonas (Remacle et al.
2001a; Cardol et al. 2002, 2008). To uncover additional
AMC loci, we undertook a screen for nuclear mutants,
resulting in complex I dysfunction. Out of 50,000 in-
sertional transformants, 22 showed slow growth in the
dark (sid for slow growth in the dark; Figure 1A), a fea-
ture of complex I mutants. A defect in complex I activity
was veriﬁed for six sid mutants and we named them
amc1 and amc3–7 (Figure 1B). The other sid mutants
were either not signiﬁcantly or only marginally reduced
in complex I activity (P-value. 0.05) (not shown). In-gel
staining for NADH dehydrogenase activity was per-
formed for all amc mutants (Figure 1C). Note that wild-
type complex I is often resolved in more than one purple
band of high molecular weight, depending on solubili-
zation conditions. The purple bands, observable at
950 kDa, correspond to the holoenzyme. These were
only present in amc3 and amc4. In the case of amc3,
while a wild-type–size complex I was detectable, the
staining was reduced (Figure 1C and supporting infor-
mation, Figure S1B). We also noted that very low levels
of complex I accumulated in amc4 (Figure S1B and
Figure S2A). This accumulation appeared to be dependent
Figure 4.—The amc mutations are recessive. Heterozygous
(amc/1) and homozygous (1/1) diploid strains were gener-
ated by crosses. (A) Complex I activities (nmol NADH oxi-
dized/min/mg of protein). Columns represent the average
of 10 independent determinations, with error bars represent-
ing SE. The 1/1 diploid activity is not shown here and was
92 6 8 nmol NADH oxidized/min/mg of protein. (B) BN-
PAGE and in-gel NBT staining of NADH dehydrogenase ac-
tivity. The black and gray arrowheads indicate the position of
mature complex I and 700-kDa subcomplex, respectively. (C).
Light/dark growth comparison of wild type (wt), amc4 and
amc5 mutants, and their respective diploids (1/1, amc4/1,
and amc5/1). Dilution series were plated on acetate contain-
ing medium and incubated 6 days in the light or 12 days in the
dark. For B and C, only representative amc/1 diploids are
shown. All amc/1 diploids exhibit restoration of the growth
in the dark and complex I assembly phenotypes (not shown).
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upon extraction, an indication that complex I is not
stable in the presence of the amc4 mutation. All other
amc mutants accumulated a 700-kDa subcomplex that
stained for NADH dehydrogenase activity (Figure 1C
and Figure S1, A and B). A similar 700-kDa subcomplex
is also detected in Chlamydomonas nd4 or nd5 mito-
chondrial mutants (Remacle et al. 2006; Cardol et al.
2008) (Figure S1B). The subcomplex in amc2 is labile,
as it was not always detected in independent extractions
(Figure S1A).
To further evaluate the complex I NADH oxidore-
ductase function in the mutants, total NADH:ferricya-
nide oxidoreductase activity was determined. Total
NADH:ferricyanide oxidoreductase activity reﬂects not
only the activity of complex I but also that of other
cellular NADH dehydrogenases (Quiles et al. 1996).
However, because most of the NADH:ferricyanide oxi-
doreductase activity in Chlamydomonas is due to the
NADH dehydrogenase activity of the peripheral arm
of complex I, the level of this activity is reduced in
complex I mutants. A strong reduction was observed
in all mutants except amc3 (Figure 1D). Overall, the
levels of reduction correlated with reduced in-gel stain-
ing for NADH dehydrogenase activity in the amc
mutants (Figure 1, C and D). All amc mutants showed
decreased whole-cell respiration when compared to
wild type (Table 1). In accord with the complex I de-
fect, the respiration in the amc mutants was rotenone
insensitive.
The amc mutants display complex I assembly defects:
To verify that the 700-kDa subcomplex observed in
amc1, -2, and -5–7 was a bona ﬁde subcomplex of com-
plex I, we carried out immunoblot analyses using anti-
bodies against two subunits of the hydrophilic arm (49
and 51 kDa). As expected for an assembly intermediate
of complex I, the 700-kDa subcomplex was detected by
the two complex I-speciﬁc antibodies (Figure 2, A and
B). In amc2, the putative subcomplex was very rarely de-
tected (not shown). On the basis of the fact that the
700-kDa band was also rarely detected by in-gel staining,
we reasoned that this subcomplex is highly unstable in
amc2.
Using an antiserum against TYKY, another subunit of
the hydrophilic arm, we also consistently detected the
700-kDa subcomplex in amc1 and amc5–7 and in some
instances in amc2 (not shown). Intermediate assembly
subcomplexes of similar size were not observed in the
wild type or in the amc3 and amc4 mutants. In addition,
low levels of complex I was evidenced in amc4 using
the anti–49-kDa antibody in instances where NADH
Figure 5.—Complemen-
tation experiments deﬁne
alleles of AMC loci. (A)
Complex I activity of the
wild type (wt) and the 19
diploids strains (amc ·
amc). The average of 10 in-
dependent replicas is indi-
cated. The error bars
represent standard error.
The activity is expressed in
nmol NADH oxidized/
min/mg of protein. (B)
Light/dark growth compar-
ison of wild type (W), amc
mutants (1, 2, and 4–7)
and respective heterozygous
diploids (D). Cells were
plated on acetate-containing
medium and incubated 3
days in the light or 5 days
in the dark. (C) BN-PAGE
and in-gel NBT staining of
NADH dehydrogenase activ-
ity. The black arrowhead
indicates the position of ma-
ture complex I. For B and C,
only representative amc ·
amc diploids are shown. All
diploids exhibiting restora-
tion of the growth in the
dark phenotype also showed
restoration of complex I as-
sembly as assessed by NBT
staining (not shown). Only
the top part of the BN gel
is shown in C.
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dehydrogenase activity was also detected by in-gel stain-
ing (Figure S2, A and B).
Low accumulation of structural subunits has been
observed in several cases of complex I deﬁciency (Saada
et al. 2009). We decided to evaluate the steady-state levels
of the three complex I subunits (49 kDa, 51 kDa, and
TYKY) in membrane extracts of the amc mutants, sepa-
rated under denaturing conditions. As shown in Figure
2C, the accumulation of TYKY and other subunits was
severely reduced in all mutants, with the exception of
amc3.
Impact of the amc mutations on respiratory com-
plexes II, III, and IV: To determine whether the amc
mutations resulted in a pleiotropic defect, activities of
other respiratory complexes were measured. All amc
mutants showed increased levels of complex II 1 III
combined activity, an indication that they compensate
for a defect in complex I (Figure 3C). Such a compen-
satory effect has already been observed in complex I
mutants of mitochondrial origin (Remacle et al.
2001a; Cardol et al. 2002). Individually, complex II
and complex III activities were not signiﬁcantly affected
(Figure 3, A and B). On average, the augmented com-
plex II 1 III combined activity correlated with the level
of reduction of complex I in all mutants. All amc
mutants with the exception of amc3 displayed wild-type
levels of complex IV activity (Figure 3D). However, we
noted that the complex IV defect seen in amc3, unlike
the complex I phenotype, was not inherited in the prog-
eny (not shown). We concluded that all amc mutants
resulted in isolated complex I deﬁciency.
Genetic analyses reveal six AMC loci: All amc/1 dip-
loid strains displayed restored levels of complex I activ-
ity (Figure 4A). In addition, complex I assembly,
assessed via BN-PAGE, was also wild type (not shown
and Figure 4, B and C). Therefore, we concluded that
all amc mutations were recessive. While all the amc
mutations were found to be monogenic, the antibiotic
resistance did not cosegregate with the sid phenotype
for any except amc5 (not shown). We concluded that
the AMC5 locus was tagged with the insertional marker.
To establish the number of complementation groups
deﬁned by the amc mutations, we performed allelism
tests. We were unable to obtain diploids from amc1 ·
amc5 and amc2 · amc4 crosses. The other 19 diploids
could be constructed and were further analyzed. Al-
though complex I activity levels did not always reach
those of the wild-type strain, we observed restoration of
a fully active complex I in most diploids (Figure 5A).
This restoration correlated with the recovery of wild-
type–like growth in the dark (Figure 5B) and NADH
dehydrogenase activity (Figure 5C). Only two combina-
tions of diploids (amc5 · amc7 and amc1 · amc7) showed
low levels of complex I activity (Figure 5A).
The amc5 · amc7 diploid accumulated the same sub-
complex as each single mutant and displayed a sid phe-
notype (Figure 6A). Moreover, all the progeny (100
meiotic products) from the amc5 to amc7 cross had
a sid phenotype and was deﬁcient in complex I activity
(Figure 6B). Thus, we concluded that amc5 and amc7
are alleles of the same locus.
The amc1 · amc7 diploid displayed a low level of
complex I activity (Figure 5A) but was restored for
the growth in the dark and complex I assembly when
assessed by BN-PAGE (Figure 6C). We concluded that
amc1 and amc7 deﬁne distinct loci.
We were not able to generate meiotic products of the
amc1 · amc5 cross. However, if amc5 and amc7 deﬁne
the same locus and amc1 and amc7 are alleles of distinct
loci, then amc1 and amc5 are nonallelic. Similarly, be-
cause we were unable to generate amc2 · amc4 diploids,
Figure 6.—amc5 and amc7 deﬁne alleles of the same AMC
locus. (A, top) Light/dark growth comparison of wild type
(W), amc5 and amc7, and the amc5/amc7 diploid (D). (A, bot-
tom) Detection of complex I and the 700-kDa subcomplex via
NADH dehydrogenase activity on membrane fractions sepa-
rated by BN-PAGE. (B, top) Light vs. dark growth of wild type
(wt) and representative spores (s1–s4) from the amc5 · amc7
cross. Note that the strains used in our study are not isogenic
and it is possible that other genetic factors segregate and
modulate the slow growth phenotype (compare s1 and s2 to
s3 and s4). (B, bottom) Complex I activities (nmol NADH
oxidized/min/mg of protein) of wild type (wt), amc5, amc7,
and two sid spores (s1 and s2) originating from the amc5 ·
amc7 cross. Columns represent the average of 10 independent
determinations, with SE as the error bars. (C, left) Light vs.
dark growth of wild type (W), amc1 and amc7mutants, and the
amc1/amc7 diploid (D). (C, right) Detection of complex I and
the 700-kDa subcomplex via NADH dehydrogenase activity on
membrane fractions separated by BN-PAGE. (A, B, and C)
Cells were plated on acetate-containing medium and incu-
bated 3 days in the light or 5 days in the dark. (A and C)
The black and gray arrowheads indicate the position of ma-
ture complex I and the 700-kDa subcomplex, respectively.
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we analyzed the segregation of the meiotic spores orig-
inating from this cross. Several spores from the amc2 ·
amc4 cross displayed faster growth in the dark (Figure
S3, top). Wild-type levels of complex I activity were also
conﬁrmed in spores exhibiting a wild-type–like growth
phenotype in the dark (Figure S3, bottom). Therefore,
we concluded that amc2 and amc4 belong to different
complementation groups. In summary, the seven amc
mutants deﬁne six nuclear loci.
The AMC5/7 locus encodes the NUOB10/PDSW en-
coding gene: Since the amc5mutant was tagged with the
insertional marker (iPm), we sought to identify the
interrupted locus by TAIL-PCR. The iPm was mapped
to intron 3 of the NUOB10 gene encoding PDSW
(according to the nomenclature of bovine complex I),
a noncore subunit of the membrane arm of complex I
(Hirst et al. 2003) (Figure 7 and Figure S4). Mitochon-
drial complex I is composed of core subunits required
for the catalytic activity and noncore subunits believed
to play a role in the assembly and/or regulation of the
activity of the enzyme (Remacle et al. 2008). While core
subunits are common to both bacterial and mitochon-
drial complex I, noncore subunits are only found in the
eukaryotic enzymes. On the basis of the failure to am-
plify the region with speciﬁc primers, the insertion of
the marker occurred at the 39 end of intron 3 and was
accompanied by a deletion of the entire coding se-
quence and the 39-UTR downstream of the integration
site (Figure 7). In amc7, PCR analyses revealed that
a molecular lesion had also occurred in the NUOB10
gene. (Figure 7). Unfortunately, despite several attempts,
we were unable to transform the amc5/amc7 mutants
with a NUOB10-containing cosmid (not shown). Almost
all the amc mutants were found to be very recalcitrant to
transformation, regardless of the transformation method
employed.
The AMC1 locus does not map to a gene encoding
a subunit of the membrane arm: As amc1 also accu-
mulated a 700-kDa subcomplex, we reasoned that the
mutation could affect 1 of the 12 nuclear-encoded sub-
units of complex I present in the membrane arm
(Lazarou et al. 2009), the NUOP1 and NUOP4 genes
encoding small hydrophobic subunits (Cardol et al.
2004) or the NUOAF1 gene encoding the CIA30 assem-
bly factor whose defect results in the accumulation of
a subcomplex (Kuffner et al. 1998; Vogel et al. 2005;
Dunning et al. 2007). The sequencing of these loci did
not reveal any mutation that could account for the phe-
notype of amc1 (Table 2). The ﬁnding of a wild-type
NUOB10 sequence in amc1 further conﬁrms that this
mutation is not allelic to amc5 and amc7 mutations.
We concluded that the amc1 mutation did not map to
a gene encoding a complex I subunit that is part of the
membrane arm.
DISCUSSION
The assembly of mitochondrial complex I is an
intricate process involving coordination of multiple
factors to yield a holoenzyme with at least 40 subunits,
one FMN molecule, and eight FeS clusters. We aimed to
further dissect this process and pursued a forward
genetics approach in the green alga C. reinhardtii to
uncover mutations (amc) resulting in loss of complex
I function. We took advantage of the fact that in this
alga, mutations inactivating complex I are not lethal
and result in a slow growth in the dark phenotype,
which facilitates visual screening of candidate mutants
(Remacle et al. 2008). We isolated six new complex I-
deﬁcient mutants, four of them resulting in the forma-
tion of intermediate assembly subcomplexes. On the
basis of our genetic analyses, all amc mutations are re-
cessive and fall into six complementation groups (Table
3). The ﬁnding that amc5 and amc7 are the only recov-
ered allelic mutations indicates that our screen is not
saturated. Even though all amc mutations result in a de-
fect in complex I activity, they appear different when
Figure 7.—The amc5 and amc7 mutants carry molecular
lesions in the NUOB10 gene encoding the noncore subunit
PDSW. (Top) Schematic representation of the NUOB10 gene
structure showing the four exons (rectangles) and three
introns (thin lines). The asterisk denotes the position of the
ATG codon while the “x” symbol indicates the position of the
stop codon. The insertional cassette (AphVIII) is represented
as an arrow (dark shading) ﬂanked by the promoter and ter-
minator regions (light shading). The positions of primers
used to diagnose the molecular lesion are indicated by small
arrows. The leftward arrow with a vertical line above intron 3
indicates the extent of the NUOB10 sequence obtained by
TAIL-PCR (Figure S3). R1 and R2 indicate the positions of
the AphVIII-speciﬁc primers used in the TAIL-PCR to recover
the sequence ﬂanking the cassette. A deletion of the promoter
occurred upon integration of the cassette in the NUOB10 lo-
cus. (Bottom) Molecular lesions in NUOB10 were analyzed by
PCR using NUOB10-speciﬁc primers. PCR products were
stained by ethidium bromide and imaged using an imaging
system (Kodak Image Station 2000R).
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examined at the level of complex I assembly (Table 3).
While amc1, -2, -5/7, and -6 accumulated a complex I
assembly intermediate in the form of a subcomplex,
amc3 and amc4 did not accumulate any subcomplexes.
The 700-kDa subcomplex was shown to contain the 51
kDa, 49 kDa, and TYKY subunits that are components of
the hydrophilic arm of complex I. Defects in ND4 and
ND5 subunits of the membrane arm also yield a 700-
kDa subcomplex (Remacle et al. 2006; Cardol et al.
2008). Overall, the accumulation of the subcomplex
indicates that amc1, -2, -4, -5/7, and -6 are disrupted
for the assembly of the membrane arm of complex I.
The amc4 mutant appears to accumulate lower amounts
of a wild-type–size complex I and is probably not de-
ﬁcient in the assembly process per se but rather for the
stability of the holoenzyme. The fact that amc3 displays
a reduced complex I activity but no change in the abun-
dance of the TYKY, 49-, and 51-kDa subunits suggests
that the enzyme is fully assembled but less active.
The amc5/7 locus was cloned and shown to corre-
spond to the NUOB10/PDSW encoding gene (Figure
7). The NUOB10/PDSW family is a poorly character-
ized protein family characterized by the presence of a C
(X)11C motif (Cardol et al. 2004). The bovine PDSW
has been found in the membrane arm (Hirst et al.
2003) and the Neurospora ortholog is an integral
membrane protein, on the basis of its lack of extract-
ability in alkali-treated samples (Videira et al. 1993). In
TABLE 2
Sequencing of complex I structural genes and NUOAF1 in the amc1 mutant
Chlamydomonas
subunit Accession no. Subcomplex H. sapiens B. taurus
Sequence obtained
Sequencing
result
bp from
ATG
bp from
STOP
ACP1 AAQ73138 a, bS NDUFAB1 SDAP 257 132 wt
NDUFA11 AAS58499 a, l NDUFA11 B14.7 299 1372 wt
NUO17 AAS48192 b NDUFB11 ESSS 2109 1130 wt
NUOA8 AAQ55460 a, l NDUFA8 PGIV 28 143 wt
NUOB10 AAQ55459 bL, bS NDUFB10 PDSW 257 1611 wt
NUOB12 AAS48194 b NDUFB3 B12 2140 1338 wt
NUOB18 AAQ73135 bS NDUFB7 B18 213 0 wt
NUOB22 AAQ73134 bS NDUFB9 B22 23 120 wt
NUOP2 AAS48193 a, bS NDUFB4 B15 2182 169 wt
NUOP1 AAS58501 ND NI NI 2133 1570 wt
NUOP4 AAS58498 ND NI NI 218 1215 wt
NUOA1 AAS48198 a NDUFA1 MWFE 263 1488 wt
NUOA9 AAQ55458 a NDUFA9 39 2233 1177 wt
NUOB16 AAQ64637 a, l NDUFA13 B16.6 2151 1656 wt
NUOB8 AAQ63699 a, l NDUFA2 B8 275 1527 wt
Assembly factor
NUOAF1 ACN88152 NDUFAF1 CIA30 213 1288 wt
The assignment of the subunits in the various subcomplexes (a, b, bS, bL, and l) is based on the predicted organization shown
in Lazarou et al. (2009). NI, not identiﬁed; ND, not determined. The location of NUOP4, only identiﬁed in Chlamydomonas
complex I, has not yet been determined experimentally (Cardol et al. 2004). NUOP1 was found in the membrane arm of
Arabidopsis complex I (Klodmann et al. 2010).
TABLE 3
Phenotype and molecular genetics of amc mutants
Strain CI activity
Fully assembled
(950 kDa)
Subcomplex
(700 kDa) Allelism Monogenic Tagged
wt 100 1111 — — — —
amc1 12 — 1 No Yes No
amc2 4 — 1 No Yes No
amc3 41 111 — No Yes No
amc4 14 1 — No Yes No
amc5 14 — 11 Yes (amc7) Yes Yes
amc6 22 — 11 No Yes No
amc7 14 — 11 Yes (amc5) Yes No
Complex I activity (CI) is indicated as % of wild type (100). 1, 11, 111, 1111, and — indicate the
relative levels of fully assembled complex I or 700-kDa subcomplexes.
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Arabidopsis, NUOB10/PDSW is found in the mem-
brane arm of complex I, associated with the hydropho-
bic subunit ND5 (Klodmann et al. 2010). This result is
in accord with the fact that single mutants affected in
ND5 (dum23, Figure S1) or NUOB10/PDSW (amc5, Fig-
ure S1) generate the same subcomplex, lacking the distal
part of the membrane domain (this study and Hirst et al.
2003; Cardol et al. 2008). The ﬁnding that the amc5
and amc7 mutants carry mutations in the NUOB10
gene validates our screening strategy for complex I
defects.
The identities of the other AMC gene products re-
vealed through our mutant screen are unknown and
can only be speculated upon at the present time. One
possibility is that the AMC loci correspond to genes
encoding bona ﬁde subunits. Alternatively, AMC loci
could encode factors required for expression or assem-
bly of complex I. Orthologs for identiﬁed assembly fac-
tors, NDUFAF3 (Saada et al. 2009), CIA30 (Dunning
et al. 2007), C20ORF7 (Sugiana et al. 2008; Gerards
et al. 2009), IND1 (Bych et al. 2008; Sheftel et al.
2009), C8ORF38 (Pagliarini et al. 2008), FOXRED1
(Fassone et al. 2010), GLDH (Pineau et al. 2008), and
candidate assembly factors (C7ORF10, MCCC2, AMACR,
LYRM5, DCI, and IVD) (Pagliarini et al. 2008) are pres-
ent in the predicted proteome of Chlamydomonas.
Whole-genome sequencing of the amc mutants should
enable the rapid identiﬁcation of the molecular lesions
causing complex I defects. Such a technology is currently
being tested in Chlamydomonas (O. Vallon, personal
communication).
To our knowledge, this is the ﬁrst description of a
mutant screen in any organism yielding mutants with an
isolated complex I deﬁciency. The variety of assembly
defects in the amc mutants suggests the corresponding
gene products (either structural subunits or assembly
factors) act at different steps of the assembly process.
This further stresses the value of Chlamydomonas as an
experimental model to address the question of complex
I assembly. This question has now received considerable
attention in plants, where complex I displays unique
features compared to its mammalian/fungal counter-
part (Braun and Zabaleta 2007; Pineau et al. 2008;
Klodmann et al. 2010) and also in humans, as most of
complex I-linked diseases still have no molecular expla-
nation (Lazarou et al. 2009).
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FIGURE S1.—Accumulation of a 700 kDa subcomplex in the amc and dum23 mutants. (A). Detection of Complex I activity in 
wild type (wt), amc1 and amc2 strains. The 700 kDa subcomplex is detected in amc1 and amc2.  (B). Detection of Complex I in wild 
type (wt), amc1 to 7 and dum23. The 700 kDa subcomplex that is detected in the dum23 mutant, which carries a molecular lesion 
in the nd5 gene, also accumulates in amc1, 2, 5, 6 and 7. Note the low accumulation of Complex I holoenzyme in amc4. (A) and 
(B). Detection of Complex I and the 700 kDa subcomplex via NADH dehydrogenase activity in-gel staining on membrane 
fractions separated by BN-PAGE. 150 µg of protein (partially purified membranes were loaded per lane). The black and grey 
arrowheads indicate the position of mature Complex I and the 700 kDa subcomplex, respectively. 
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FIGURE S2.—The amc3 mutant accumulates low amounts of Complex I.  (A). Detection of Complex I and the 700 kDa 
subcomplex via NADH dehydrogenase activity. Membrane fractions of amc3, 4 and 5 were separated by BN-PAGE and stained 
in gel for NADH dehydrogenase activity. The black and grey arrowheads indicate the position of mature Complex I and the 700 
kDa subcomplex, respectively. (B). Immunoblot analysis of membrane fractions from wild type amc1 to 7 separated by BN-PAGE 
using anti-49 kDa. 150 µg protein of partially purified membranes were loaded per lane. The bottom panel shows a non specific 
band detected by the anti-49 kDa that serves as a loading control.  
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FIGURE S3.—amc2 and amc4 define alleles of different AMC loci. (top) Light (L) versus dark (DK) growth of wild type (wt), amc2, 
amc4 and several representative spores (s1 through s5) from the amc2 x amc4 cross. Cells were plated on acetate containing medium 
and incubated three days in the light and five days in the dark. (bottom) Complex I activities (nmol NADH oxidized per minute per 
mg protein) of wild type (wt) and representative wild type (s1, s2, s4, s5) and sid spores (s3, s6, s7,s8) originating from the amc2 x 
amc4 cross. Columns represent the average of ten independent determinations, with S.E. as the error bars. 
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FIGURE S4.—Sequence of TAIL-PCR product obtained from the amc5 mutant. The capitalized letters in bold correspond to 
the sequence of the HSP70/RBCS2 promoter in the insertional cassette interrupting the NUOB10 gene. The small letters indicate 
additional nucleotides that are not part of the insertional cassette or the NUOB10 genomic sequence and probably were 
incorporated upon insertion at the integration site. The underlined capitalized letters correspond to the reverse complement 
sequence of bases 419 to 573 of the NUOB10 intron 3. 
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PART II. ALTERNATIVE STRATEGIES TO RETRIEVE MUTATIONS THAT DO 
NOT COSEGREGATE WITH TRANSGENE IN FORWARD GENETIC SCREEN    
A major goal in a forward genetics analysis is to carry out a mutagenesis in a way that most 
mutants undergo a single insertion event involving an intact transgene.This is needed to ensure 
the co-segregation of the mutant phenotype and the selectable marker, thus allowing the 
researcher to retrieve the genomic DNA that flanks the insertion locus by methods such as TAIL-
PCR (Barbieri, Larosa et al. 2011). Even if the method we used was optimized to lead to a single 
insertion of an intact transgene, some interesting complex I mutants isolated don’t arbor a 
cosegregation between the complex I phenotype and the hygromycin cassette (Barbieri, Larosa 
et al. 2011). This is the case for amc4 that seems really interesting because it is the first time 
that a complex I mutant accumulating a reduced level of the complex I holoenzyme (950 kDa) 
was isolated. To date, most of the mutants characterized eitherfail to accumulate a mature 
complex or accumulate a subcomplexe of 750 kDa (Cardol, Matagne et al. 2002). 
These untagged mutations could have arisen spontaneously during the mutagenesis 
procedure (ex: during electroporation which could be mutagenic by itself). In general, 
integration of DNA in Chlamydomonas genome is associated with a deletion of a part of the 
chromosome at the integration site. Alternatively, more than one insertion could have occurred, 
of which one was unstable and was eliminated before cell division, leaving a mutation not linked 
to the antibiotic resistance (Pazour and Witman 2000). Another hypothesis could be due to the 
use of herring sperm DNA in the experimental procedure. Such carrier DNA was described to 
increase the transformation efficiency ((Shimogawara, Fujiwara et al. 1998)), but mutants in 
which mutations were the consequence of herring sperm DNA insertion were already found 
(Smart and Selman 1991). To avoid such mutation, in future generation of insertion mutant 
library, we will not use herring sperm DNA anymore. A last, hypothesis could be that the 
untagged mutations spontaneously arose in some complex I gene. However, this is unlikely 
because it would require a very high spontaneous mutation frequency, which we have not 
observed in these cell lines. Similarly “untagged” mutants have been recovered in other screens 
based on insertion mutagenesis (Tam and Lefebvre 1993; Gumpel, Ralley et al. 1995; Pazour, 
Sineshchekov et al. 1995).  
In this part, we focus on alternatives methods to retrieve the mutation involved in the 
complex-I deficiency phenotype found in amc4.  
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Table 2 : Percentage of marker segregation    Table 3 : Analyze of the co-segregation between 
the amc4 phenotype and the hygromycin 
resistance marker 
 
 
 
 
 
 
  
 
Figure 11 :  Results from the crossing between amc4 
and a wild type strain in order to establish the co-
segregation between the complex I deficiency 
phenotype and the hygromycin resistance cassette. 
The reduced heterotrophic growth characteristic for 
complex I mutants (amc4, P1, P3) is assessed in (A). 
The resistance to hygromycin is shown for amc4, P1 to 
P5 in (B). The molecular presence or absence of the 
hygromycin cassette (± 1700 bp) is visualized by PCR 
analysis for 6 progenies P1, to P6 in (C). The 
segregation of arginine auxotrophy, a genetic marker 
of amc4 is shown in (D). The mating type (mt
+ : ± 600 
bp and mt
-
 : ± 700 bp) of a strain could be visualized by 
PCR analysis in (E). D1 in (E), shows a diploid status 
that could concern a few percentage of the progeny. .  
Hygromycin Complex I %  
+ - 35 Parental (amc4) 
- + 29 Parental (wt) 
+ + 23 Recombinant 
- - 14 Recombinant 
 -  (in %) +   (in %) 
(A) Complex I 49 51 
(B) Hygromycin 43 30 
(C) Hygromycin (PCR) 43 57 
(D) Arginine 48 52 
(E) Mating type 40 
5 (5 for 
diploids) 
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II.1. GENETIC ANALYSIS  
In order to assess the co-segregation between amc4 and the hygromycin resistance 
cassette, we crossed the complex deficient (CI-), hygromycin resistant (HygR), arginine 
auxotrophe (arg-), and mating type minus (mt-) amc4 mutant with the wild type strain (CI+, HygS, 
arg+, mt+) and made a bulk analysis (Fig. 11). The phenotype of 300 meiotic clones from the 
progeny was analyzed, for complex I deficiency (Fig. 11A), hygromycin resistance (Fig. 11B and 
C), arginine auxotrophy (Fig. 11D) and mating type (Fig. 11E).  
First of all, we noticed that complex I deficiency presented a Mendelian transmission, 
meaning that only one single mutation was responsible for the observed complex I- phenotype 
(Fig. 11A and Table 2). In addition, the mating-type locus as well as the arginine auxotrophy also 
segregated in a mendelian fashion, meaning that there was no bias in our cross (Fig. 11D and E 
and Table 2). After zygotes germination, a percentage of the progeny could keep a diploid status 
(Table 2). These diploids could be visualized because they present both mating type character 
such as D1 in Fig. 11E.  
The resistance to hygromycin was also analyzed, first on the basis of the capacity of the 
cells to growth on a hygromycin rich medium (Fig. 11B, Table 2). Results showed that there was 
a bias in favor of the sensitive meiotic products. The presence of the cassette was also assessed 
by PCR analysis (Fig. 11 C, Table 2). In that case, the segregation was mendelian, meaning that 
some meiotic products, such as P3, although they did not grow on hygromycin rich medium, did 
possess the cassette. This thus suggests that a mechanism of silencing of the cassette had 
occurred in certain meiotic products (around 20%). Such a silencing mechanism was previously 
demonstrated in Chlamydomonas  (Cerutti, Johnson et al. 1997) and can lead to serious 
problems for the application of transgenic technologies.  
In addition, we analyzed the cosegregation between the cassette and the complex I- 
phenotype (Table 3). Unfortunately, 37% of the meiotic products were recombinant for the two 
markers (Hyg+ complex I+ or Hyg- complex I-), meaning that the two genes are not linked (Table 
3). We will thus not be able to retrieve the gene involved in the amc4 phenotype by traditional 
analysis such as TAIL-PCR. 
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BOX 1: Biochemical characterization of amc8 mutant realized by 
  N. Subrahmanian in Prof. Hamel Laboratory 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Box 1: (A) Phenotypic and (B-E) biochemical characterization of amc8 mutant. amc8 comes 
from the same genetic background as amc4 and shows (B) an unstable but fully assembled 
complex I. (C) NADH:Ubiquinone oxydoreductase activity , relative to complex I, is 75% 
reduced and (C) complex II+III activity is slightly increased, which is characteristic of complex I 
mutants. (E) amc8 complex IV activity is comparable to a wild type activity 
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II.2. HIGH THROUGHPUT GENOME SEQUENCING, THE LAST BUT NOT LEAST 
ALTERNATIVE TO RETRIEVE UNTAGGED GENES IN INSERTION MUTANTS 
II.2 (1) ABANDONED APPROACH  
Map-Based Cloning can be used as an alternative to localize on the genome all classes of 
mutations. This technique relies on two basic principles, namely the existence of a genetic map 
and the ability to generate progeny of sexual crosses that segregate for the trait of interest as 
well as for phenotypic and/or molecular markers.  
The map-based cloning in C. reinhardtii is possible (Rymarquis, Handley et al. 2005) because 
unknown localized mutations can be mapped by crossing the mutant of interest with the 
interfertile strain known as Chlamydomonas grossii, S1-D2 (or CC-2290), which has a suitable 
profusion of sequence tagged sites (STS), cleavable amplified polymorphic sequence (CAPS), 
single nucleotide polymorphism (SNP), and RFLP markers (Gross, Ranum et al. 1988; Vysotskaia, 
Curtis et al. 2001; Grossman, Harris et al. 2003). Beginning with laborious RFLP-based mapping 
(Gross, Ranum et al. 1988), Chlamydomonas mapping has moved toward a PCR-based method 
(Kathir, LaVoie et al. 2003).  
In our case, there was a genetic incompatibility with amc4; the complex I deficient tetrads, 
obtained during the crossing between amc4 and S1-D2, aborted and it was impossible thus 
impossible to analyse the complex I deficiency progeny necessary in map-based cloning method.  
II.2 (2) IN PROCESS ALTERNATIVE; HIGH THROUGHPUT SEQUENCING  
Our last, but not least, alternative in order to retrieve this mutation is the use of the next 
generation sequencing. Our first approach, currently in process, is to compare two complex I 
mutants, coming from the same genetic background, with the Chlamydomonas reinhardtii 
reference nuclear genome, obtained from a strain coming from a different genetic background 
than our insertion mutants. Indeed genetic differences arise between individuals, in the form of 
structural variations, such as deletions and duplications, or in the form of point mutations. If a 
difference is identified in both mutants, it is probable that this is just a genetic variation. In 
contrast, if a variation is only observed in one mutant, this one could be a mutation involving 
the complex I phenotype. Using this, the entire genome of amc4 (Barbieri, Larosa et al. 2011) 
and amc8, an insertion mutant coming from the same genetic background (detailed in Box1) 
were sequenced. 
Present-day, next generation sequencing, also identified as high-throughput sequencing 
(HTS) techniques, routinely produce a flood of genomic information, but so far the great 
challenge for wet-lab biologists is to analyze it. In fact, illumina sequencing technology, the 
technique used in our study, typically produces 50–200 million of 32–100 bp (100 bp in our case) 
sequences (termed reads) in a single run of the machine, each run lasting about one week. This 
is a huge amount of data to handle. In our case, reads were “Paired-Ended”, meaning that we 
sequenced both ends of each DNA fragment rather than just one. Typical applications of HTS are 
de-novo sequencing, alignment resequencing, epigenetic analyses such as methylation, 
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transcriptomic analysis (RNA-Seq), protein-nucleic acid interactions (such as in chromatine 
immunoprecipitation sequencing; ChIP-seq).   
The decision to use either strategy is based on the intended biological application as well 
as cost, effort and time considerations. In our case, we decided to start by the alignment 
resequencing. In fact, identifying and cataloguing genetic variation in multiple strains of highly 
related genomes can be accomplished by aligning reads to the corresponding reference 
genome. For this technique, the availability of such a reference genome for the organism under 
study is necessary (Chlamydomonas reinhardtii genome available on www.phytozome.com; 
(Merchant, Prochnik et al. 2007) ) and the reads need to be aligned (or mapped in HTS jargon) to 
the reference genome. 
II.2 (3) RESULTS; MAPPING TO THE REFERENCE GENOME  
Mapping a large volume of reads to a large genome poses a great challenge to traditional 
sequence alignment programs (such as BLAST). To meet the requirements of efficient and 
accurate short read mapping, many new alignment programs have been developed. Paired-end 
reads from amc4 and amc8 sequencing were mapped to the Chlamydomonas reinhardtii 
reference genome using the software package BWA (Burrows-Wheeler Aligner). BWA is 
designed to achieve a good balance between performance and accuracy (Li and Durbin 2009). It 
works for paired-end reads and produces output files in the standard SAM format. BWA first 
finds the positions of all the good hits for each read, sorts them according to the chromosomal 
coordinates and then does a linear scan through all the potential hits to pair the two ends. (Li 
and Durbin 2009).  Two other software packages were used to post-process the SAM files in 
order to prepare them for visualization. SAMtools was used for SAM to BAM conversion and 
indexation of the BAM files while Picard was used to flag the PCR duplicates. 
After mapping and post-processing, reads are visualized with “The Integrative Genomics 
Viewer” (IGV) (Robinson, Thorvaldsdottir et al. 2011), a visualization tool for interactive 
exploration of large, integrated genomic datasets usable on standard desktop computers, 
excellent for wet-lab biologist. It supports a wide variety of data types, including next-
generation sequence data, and genomic annotations. Navigation through a data set allows the 
user to zoom and span seamlessly across the genome at any level of detail from whole genome 
to base pair (Robinson, Thorvaldsdottir et al. 2011).  
Our analyses of two DNA libraries prepared and sequenced using the Illumina sequencing 
technology platform revealed that 229 million and 146 million paired reads had been generated, 
each 100 nt long for amc4 and amc8, respectively.  
Of the amc4 reads, ~179 million (78%) reads were of sufficient quality that both ends mapped 
back to the current Chlamydomonas reinhardtii reference genome assembly, whereas there 
were ~3 million reads (1.5%) for which only one end mapped back.   
Of the amc8 reads,  ~109 million (75%) were of sufficient quality that both ends mapped back to 
reference genome assembly, whereas there were ~3 million reads (2%) for which only one end 
mapped back.   
In this study, we excluded several other classes of reads such as PCR duplicates. In fact, 
Picard algorithm identified 17% of PCR duplicate reads for amc4 and 86% for amc8. These 
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results revealed a huge difference in quality between the amc4 and amc8 libraries. Sequencing 
results are much better for amc4 than for amc8.  
We also excluded reads from the mitochondrial and chloroplastic genomes. 
II.2 (4) FIRST STEP, READ COVERAGE ANALYSIS  
 In IGV genomic data can be visualized, including basic aligned read data as well as 
derived results, such as read coverage (Fig. 12). Coverage data are often useful for assessing 
overall quality and diagnosing technical issues in sequencing runs, and to analyze ChIP-Seq 
(Guttman, Amit et al. 2009) and RNA-Seq (Berger, Levin et al. 2010) experiments. The first step 
of our strategy is to identify coverage differences between amc4 and amc8, of which some 
could be due to deletions associated to the mutant phenotype. This analysis is akin to those 
looking for copy-number variants (CNVs) between re-sequenced genomes. In theory, assuming 
that the sequencing process is uniform, the number of reads mapping to a region is expected to 
be proportional to the number of times the region appears in the analyzed sample. Thus, a 
region that has been deleted (or duplicated) will have less (or more) reads mapping to it. The 
first study to use these ‘gain/loss’ signatures to detect CNVs between tumor and healthy 
samples of the same individuals was realized in 2008 by (Campbell, Stephens et al. 2008).  
So far, coverage differences were inventoried in 3 chromosomes (Table. 4). 
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Table 4 : Coverage differences inventoried in Chlamydomonas chromosomes.  
Mutant 
Type of rearrangement 
 
Chromosome Localization 
(Gap size) 
 
Gene involved Gene annotations 
amc4 Deletion 
Cr01: 3483 – 3484 kb 
(1kb) 
Cre01.g023650 
Bidirectional amino 
acid transporter 
amc4 Deletion 
Cr01: 8190 – 8200 kb 
(10kb) 
Cre01.g058550  
amc8 Deletion 
Cr01: 2192,5 – 2193 kb 
(0.5 kb) 
Cre01.g013050 
Galactose 
oxidase/kelch repeat 
superfamily protein 
amc8 Deletion 
Cr01: 2480.5 – 2481.5 kb 
(1 kb) 
Cre01.g015600 Ilityhia 
amc8 Deletion 
Cr01: 3140 – 3150 kb 
(10 kb) 
Cre01.g021100  
amc8 Deletion 
Cr01: 3347 – 3351 kb 
(4kb) 
Cre01.g022750  
amc8 Deletion 
Cr01: 3611 – 3611,2 kb 
(0.2 kb) 
Cre01.g024400 
Tetratricopeptide 
repeat Like super 
family protein 
amc8 Deletion 
Cr01: 4203 – 4205 kb 
(2kb) 
Cre01.g029550  
amc8 Deletion 
Cr01: 4837 – 4837,5 kb 
(0.5 kb) 
Cre01.g034500  
amc4 Deletion 
Cr02: 4902.8 – 4903 kb 
(0.2 kb) 
Cre02.g110850 
PAS Domain 
containing protein 
tyrosine kinase family 
protein 
amc4 Deletion 
Cr02: 5650 – 5553 kb 
(3 kb) 
Cre02.g117000  
amc8 Deletion 
Cr02: 2323 – 2325 kb 
(2 kb) 
Cre02.g091500  
amc8 Deletion 
Cr02: 3416 – 3420 kb 
(4 kb) 
Cre02.g099100 
Ubiquitin-protein 
ligase 
amc8 Deletion 
Cr02: 3903.5 – 3904.5 kb 
(1 kb) 
Cre02.g102850  
amc8 Deletion 
Cr02: 4344 – 4347 kb 
(3 kb) 
Cre02.g106250 RNA Binding protein 
amc8 Deletion 
Cr02: 7136.5 – 7137.5 kb 
(1kb) 
Cre02.g128950 
ENTH/ANTH/VHS 
superfamily protein 
amc8 Deletion 
Cr02: 8938 – 8943 kb 
(5kb) 
Cre02. g140250 
ACT-like protein 
tyrosine kinase family 
protein 
amc4 Duplication 
Cr03: 5094 – 5104.5 kb 
(0.5 kb) 
 
Cre03.g191650  
amc8 Duplication 
Cr03: 2586 – 2588 kb 
(2 kb) 
Cre03.g168050 
Transcription factor 
GTE6 
amc8 Duplication 
Cr03: 1770 – 1772 kb 
(2kb) 
Cre03.g161800 
ATPases nucleotide 
binding 
amc8 Deletion 
Cr03: 1660 – 1668 kb 
(8kb) 
Cre03.g160900 
Protein tyrosine kinase 
family protein 
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Figure 12 : Data visualization in IGV. The read coverage and the read alignement could be seen at the same time. When using 
read coverage information, the number of reads mapping to a region is expected to be proportional to the number of times the 
region appears in the analyzed sample. Thus, a region that has been deleted (D) (or duplicated (2X)) will have less (or more) 
reads mapping to it 
 
 
 
 
Figure 12 
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Figure 14 : Representation of 
Paired-Ends orientation analysis 
visualized using IGV. (A)When no 
differences between our 
sequencing subject and the 
reference genome occur, Paired-
Ends show a regular profile. (B) 
In the case of a deletion, a 
section of DNA is missing in the 
subject genome with respect to 
the reference genome; the read 
not containing this DNA section, 
overpasses it and seems greater 
than expected. (C) In the case of 
insertions, a larger section of 
DNA is present in the subject 
genome but is not part of the 
reference genome; the read 
spans on a region inexisting on 
the reference genome, stops and 
thus seems smaller. (D) 
Unexpected pair orientations can 
be observed in case of inversion, 
such as (E) chromosomal 
rearrangements. Aberrant 
paired-end mappings appear in a 
different color and each 
chromosome is assigned a 
unique color.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13 : Structural variation 
sequence signatures. Analytical 
approaches used to detect 
structural variation; read-pair (RP) 
and assembly methods can be used 
to discover variants from all classes 
of structural variant (SV). However, 
read-depth approaches can be used 
to detect only losses (deletions) 
and gains (duplications), and 
cannot discriminate between 
tandem and interspersed 
duplications. (Alkan, Coe et al. 
2011) 
69 
 
 
II.2 (5) PERSPECTIVES 
Once genomes are screened for coverage, large deletions will lead to establishing a list 
of candidate genes possibly involved in amc4 and amc8 phenotypes. The probability of these 
genes to be linked to respiratory processes, and especially to complex I assembly, will be 
assessed by bioinformatic analysis. We are aware that the only events detectable by read 
coverage analysis are major deletion and duplication events (Fig. 13). If such events were not 
found, a simple read coverage analysis would not allow us to identify other kind of events such 
as inversions and insertions of foreign sequences (e.g., hygromycin cassette). Alternative 
strategies such as paired-end (mate-pair) orientation analysis or contigs analysis could 
overcome read coverage analysis limitations (Fig. 13)  
The first alternative to read coverage could be the study of paired-end orientation (read 
pair in Fig. 13). In fact, when zoomed below the 50-kb range, individual aligned reads become 
visible (Read alignment in Fig. 12). At this resolution, IGV uses a color code to flag paired-ends if 
their insert sizes are larger or shorter than expected, fall on different chromosomes or have  
unexpected pair orientations (summarized in Fig. 14). Such flagged pairs, when consistent across 
multiple reads, can be indicative of a genomic rearrangement. Two of the easiest and most 
commonly detected signatures are the ‘insertion’ and ‘deletion’ (Medvedev, Stanciu et al. 2009).  
In the case of deletions, a large section of DNA is missing in the subject genome with 
respect to the reference genome, a reads in this zone overpass the deletion and show a greater 
insert size than expected (Fig. 14B). Conversly, in an insertion event, a larger section of DNA is 
present in the subject genome (Fig. 14C) but is not part of the reference genome. Reads spans to 
the insertion event that are no corresponding to any regions of the reference, stop and thus the 
inferred distance is smaller (Fig. 14C). Insertion and deletion events can be identified in IGV 
because reads are colored red (for deletion) and in blue (for insertion) (Fig. 14B and C). 
Unexpected pair orientations can be observed in case of inversion. An inversion is a large section 
of DNA that is reversed in the subject genome compared to the reference genome. When an 
inversion shows up in paired-end reads, this could be visible because a different color is assigned 
to inverted reads (Fig 14D). Moreover each chromosome is assigned a unique color (FIG 14E). 
Thus chromosomal rearrangements are readily distinguished because aberrant paired-end 
mappings appear in a different color (Fig. 14E). We note that misalignments, particularly in 
repeat regions, can also yield unexpected insert sizes and can be diagnosed with the IGV.  
Detection of such events are more likely with larger fragment libraries, such as Illumina mate 
pairs (not paired-end) because the biggest limitation using short paired-end reads is indeed that 
they are short. Limitations to the alignment approach using paired-end reads are that it is 
possible to map reads within repetitive regions in the reference genome or in regions that may 
not exist in the reference genome (Frazer, Murray et al. 2009); the latter situation may result 
from gaps in the reference genome or from structural variation (SV) between the reference 
genome and the genome being analyzed. Mate-pair reads, from 2 to 10 kb, are longer than 
paired-reads and could resolve these limitations. In fact, mate pairs are created in a different 
way; the genomic DNA is fragmented and size-selected (600bp-6kb). Following, a circularization 
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step occurred by means of an internal adaptor. The circularized fragment is then randomly 
sheared, and segments containing the adaptor are purified. Finally, mate-pair reads are 
generated by sequencing around the adaptor. Reads are longer, and lead to advantages such as 
better placement of unique tags, higher coverage and the ability to detect structural changes 
(Medvedev, Stanciu et al. 2009). Indeed, a longer read could cover and overpass a longer 
deletion; mate paired will be more visible in IGV when focusing in such events.  
If these mapping methods do not allow us to find a candidate gene for the mutant 
phenotypes, a semi de novo (local-assembly) or a full de novo approach could be intended to 
discover all classes of structural variant (assembly in Fig. 13). In a semi de novo approach, longer 
sequences are generated and mapped to the reference genome, leading to contig maps. In HTS 
DNA sequencing projects, a contig (from contiguous) is a set of overlapping DNA segments 
derived from a single genetic source. Contigs can be assembled from reads that failed to map to 
the reference. These longer de novo sequences can then be mapped to the reference genome 
using traditional aligners. Such an analysis is intermediate between reference mapping and full 
de-novo sequencing. Hence, contig maps created by aligning several contigs are interesting 
because they provide the ability to study a complete, and often large, segment of the genome 
by examining a series of overlapping clones that provide an unbroken succession of information 
about that region. Such an approach has been already used in (Bos, Schuenemann et al. 2011).  
Traditional de novo approach analysis still remains a great challenge for DNA sequencing 
and there are specific problems for HTS which produces short reads with a high error rate 
(Imelfort and Edwards 2009). A number of assemblers have been developed on two principles, 
string-based and graph-based. String-based assemblers, implemented with Greedy-extension 
algorithm, were mainly reported for the assembly of small genomes (Dohm, Lottaz et al. 2007; 
Jeck, Reinhardt et al. 2007; Warren, Sutton et al. 2007; Bryant, Wong et al. 2009), while the 
graph-based ones were generally designed to handle large genomes (Simpson, Wong et al. 
2009; Li, Fan et al. 2010; Li, Zhu et al. 2010). Literature suggests that the ALLPATHS-LG could be 
a good choice for ~100 bp short reads assembly coming from Illumina platform (Gnerre, 
Maccallum et al. 2011). The ALLPATHS-LG program is available at 
http://www.broadinstitute.org/science/programs/genome-biology/crd. If a de novo alignment is 
required the next steps will be as the ones intended for our current strategy; compare both 
mutants and generated a list of potential candidates.   
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PART I. RECONSTRUCTION OF A HUMAN MITOCHONDRIAL COMPLEX I 
MUTATION IN THE UNICELLULAR GREEN ALGA CHLAMYDOMONAS 
(LAROSA, COOSEMANS ET AL. 2012) 
The pathogenicity of a given human mitochondrial mutation can be difficult to analyze 
because the mitochondrial genome harbors large numbers of polymorphic base changes that 
have no pathogenic significance (DiMauro 2007). In addition, mitochondrial mutations are 
usually found in the heteroplasmic state, which could hide the biochemical effect of the 
mutation. Human mitochondrial mutations can be reconstructed in the yeast S. cerevisiae 
(Blakely, Mitchell et al. 2005) except for complex I mutations because S. cerevisiae is lacking 
complex I and oxidizes NADH via a monomeric type-II NADH dehydrogenase (Buschges, 
Bahrenberg et al. 1994). As a substitute, bacterial systems have been used to reconstruct human 
pathogenic mutations (Blakely, Mitchell et al. 2005; Torres-Bacete, Nakamaru-Ogiso et al. 2007) 
but are not ideal because the membrane domain of eukaryotic complex I is much more complex 
than the corresponding arm from bacterial complex I (28 subunits versus 7 subunits). We 
propose in 2012 (Larosa, Coosemans et al. 2012) that the unicellular green alga Chlamydomonas 
could represent an attractive eukaryotic system to study such mutations because (1) 
respiratory-deficient mutants are viable and mitochondrial mutations are found in the 
homoplasmic state (Remacle, Baurain et al. 2001; Remacle, Duby et al. 2001), (2) transformation 
of the mitochondrial genome is feasible (Remacle, Cardol et al. 2006), (3) Chlamydomonas 
complex I is close to that of humans (Cardol, Vanrobaeys et al. 2004; Cardol 2011). To illustrate 
that, we have introduced a Leu157Pro substitution in the Chlamydomonas ND4 subunit of 
complex I of two different recipient strains by biolistic transformation, demonstrating that site-
directed mutagenesis of the Chlamydomonas mitochondrial genome is possible. This 
substitution did not lead to any respiratory enzyme defect when it is present in the 
heteroplasmic state in a patient presenting chronic progressive external ophthalmoplegia. When 
present in the homoplasmic state in the alga, the mutation does not prevent the assembly of 
the 950 kDa whole complex I which conserves nearly all the NADH dehydrogenase activity of the 
peripheral arm. However, the NADH:duroquinone oxidoreductase activity is strongly reduced, 
suggesting that the substitution could affect ubiquinone fixation to the membrane domain. The 
in vitro defects are correlated in vivo with a decrease in dark respiration and growth rate.  
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demonstrate because the mitochondrial genome harbors
large numbers of polymorphic base changes that have no
pathogenic significance (DiMauro and Schon, 2001; DiM-
auro, 2007). In addition, mitochondrial mutations are
usually found in a heteroplasmic state, which may hide
the biochemical effect of the mutation, such as decreased
respiratory activity. As human mitochondrial transforma-
tion is not yet possible, a simple living organism in which
mutations can be easily reconstructed is useful. Human
mitochondrial mutations can be reconstructed in the yeast
Saccharomyces cerevisiae (Blakely et al., 2005), except for
complex I mutations because S. cerevisiae lacks complex I
and oxidizes NADH via a monomeric type II NADH dehy-
drogenase (Buschges et al., 1994). As a substitute, bacterial
systems have been used to reconstruct human pathogenic
mutations (Lunardi et al., 1998), but these are not ideal
because the membrane domain of eukaryotic complex I is
much more complex than the corresponding arm from
bacterial complex I (28 subunits versus seven subunits).
However, the unicellular green alga Chlamydomonas rep-
resents an attractive eukaryotic system to introduce
potential pathogenic mitochondrial mutations into com-
plex I genes for several reasons: (i) the subunit composi-
tion of its mitochondrial complex I has been established
and is similar to that of the human purified holoenzyme
(Cardol et al., 2004; Cardol, 2011), (ii) the algal mitochon-
drial genome can be manipulated (Remacle et al., 2006),
and (iii) mitochondrial mutations are homoplasmic, facili-
tating determination of a link between genotype and
phenotype (Remacle et al., 2001a,b).
To illustrate the possibility of using Chlamydomonas as
a tool for the study of human complex I mitochondrial
mutations, we have chosen the T11232C transition in the
human nd4 gene (Pulkes et al., 2003), which is responsi-
ble for a Leu158Pro substitution in the corresponding
subunit. This mutation was described as a somatic
mitochondrial mutation (Pulkes et al., 2003), and was
classified as ‘probably’ pathogenic according to the
scoring method proposed by Mitchell et al. (2006) to
determine the likelihood that a given sequence is patho-
genic. In accordance with this putative pathogenicity, the
mutation has a ‘provisional’ status on the MITOMAP
website (http://www.mitomap.org). The mutation has been
found in the heteroplasmic state in one patient who
presented chronic progressive external ophthalmoplegia
(Pulkes et al., 2003).
This paper demonstrates that the Leu158Pro substitution
(position 157 in Chlamydomonas ND4) does indeed have an
impact on the activity of algal complex I when present in the
homoplasmic state. The in vitro defects correlate with a
decrease in dark respiration and growth rates in vivo, but do
not lead to enhanced hydrogen peroxide production and do
not affect membrane potential.
RESULTS
Homoplasmic Leu ﬁ Pro transformants in Chlamydo-
monas ND4 isolated from different strains
The Leu158Pro substitution in human ND4 is located in a
conserved region corresponding to amino acid 157 in
Chlamydomonas (Figure 1a). To introduce this amino acid
substitution in the corresponding subunit of the Chla-
mydomonas mitochondrial genome, we designed a pND4-
LP plasmid that extends from the terminal region of the
genome up to the nd5 gene and bears a TTG (Leu) ﬁ CCA
Figure 1. Characterization of LP1 and LP2 transformants.
(a) Partial alignment between the C. reinhardtii (Cr) and the human (Hs) ND4
subunit. Residues highlighted in black are fully conserved. Gray highlighting
indicates residues with similar properties. The Leu158Pro substitution is
indicated by an arrow.
(b) Partial physical map of the linear 15.8 kb mitochondrial genome of
C. reinhardtii. Rectangles represent protein-coding genes: cob, gene enco-
ding apocytochrome b of complex III; nd1, 2, 4, 5 and 6, genes encoding the
corresponding subunits of complex I; cox1, gene encoding subunit 1 of
complex IV, rtl, gene encoding a reverse transcriptase-like protein. The
positions of the Ddum11 and Ddum22 deletions are indicated. The portion of
the mitochondrial genome contained in plasmid pND4-LP is shown. Primers
used for PCR amplifications and restriction sites (SacI and Eco57MI) are
indicated. The origin and direction of transcription between nd5 and cox1 are
indicated by arrows.
(c) RFLP-based screening using Eco57M1. The difference between T1 and LP1
(derived from dum11) and T2 and LP2 (derived from dum22) is shown by the
presence of two fragments in LP1 and LP2.
(d) Electrophoretogram of the partial sequence of the nd4 gene in T1 and LP1.
The wild-type TTG (L) codon is present in T1, in contrast to the mutated CCA
(P) codon that is present in the homoplasmic state in LP1.
(e) Southern blots of total SacI-digested DNA from wild-type (WT), dum11, T1,
T2, LP1 and LP2 strains were probed with digoxigenin-labeled PCR fragments
of nd2 and cob.
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(Pro) codon change at position 157 of nd4 (Figure 1b). This
plasmid was used to transform two deletion mutants (Fig-
ure 1b). The dum11 mutant has suffered a terminal deletion
of the mitochondrial DNA, including part of the cob gene
(Remacle et al., 2006). The dum22 mutant has suffered a
larger deletion that extends up to the nd4 gene (Remacle
et al., 2001b). Colonies with restored heterotrophic growth
were selected after 2 months in the dark on medium
containing acetate as the organic carbon source. Use of
the CCA codon created an Eco57MI restriction site
(5¢CTGRAG(N)16ﬂ3¢) in the nd4 gene (Figure 1b). To detect
this restriction site, a 450 bp PCR fragment was amplified
using primers nd4-F/nd4-R (Figure 1b) from both the pND4-
LP plasmid and the wild-type total DNA. Figure 1(c) shows
that the pND4-LP plasmid produced two fragments of 204
and 246 bp after digestion with the Eco57MI enzyme, while
the wild-type DNA produced a single band corresponding to
undigested DNA. Three hundred colonies were then
screened for the TTG (Leu) ﬁ CCA (Pro) codon change for
the dum11 recipient strain, and one transformant (LP1) was
shown to carry the mutation (Figure 1c). Other transfor-
mants, such as T1, did not carry the mutation because the
recombination event between the exogenous DNA plasmid
and the endogenous mitochondrial genome occurred to the
left of the TTG (Leu) ﬁ CCA (Pro) codon change.
Sequencing of the nd4 gene confirmed that the codon
change was present in the homoplasmic state in the LP1
transformant (Figure 1d), in contrast to T1, in which the
mutation was absent. Only two transformants were recov-
ered after transformation of the dum22 recipient strain. As
shown in Figure 1(c), one displayed the TTG (Leu) ﬁ CCA
(Pro) codon change (LP2) and the other did not (T2).
Sequencing of the nd4 gene confirmed the presence of the
mutation in LP2 (data not shown). Sequencing of the cob
and nd5 genes showed that the transformants did not
present any changes in these genes compared to the wild-
type sequence. To analyze the mitochondrial genome as a
whole, a Southern blot of SacI-digested total DNA of T1, LP1,
T2 and LP2 was then hybridized with two probes, one located
in nd2 (nd2-F/nd2-R) and the other in cob (cob-F/cob-R)
(Figure 1b). Using the nd2 probe, only one band was de-
tected at 10 kb for all the strains analyzed, including the
dum11 recipient strain, which is not affected in this part of
the genome (Figure 1e). In contrast, using the cob probe, all
four transformants produced a signal at 5.4 kb like the wild-
type strain, but the dum11 strain produced no signal, con-
firming deletion of this gene in the mutant (Figure 1e).
Altogether, these results show that the LP1 and LP2 trans-
formants have a mitochondrial genome that is identical to
the wild-type sequence except for the TTG (Leu) ﬁ CCA
(Pro) codon change in nd4.
Activity of complex I is impaired in both LP1 and LP2
Activities of respiratory complexes were measured for
membrane fractions of T1, LP1, T2 and LP2 (Figure 2 and
Tables S1 and S2). A significant reduction (P < 0.05) in the
Figure 2. Respiratory enzyme activities of T1, LP1, T2 and LP2 strains.
Respiratory activities were measured on membrane fractions of T1, LP1, T2 and LP2 and are expressed as a percentage of that for T1. NADH:duroquinone refers to
the rotenone-sensitive NADH:duroquinone oxidoreductase activity (100% corresponds to 83 nmol NADH oxidized min)1 mg protein)1); NADH:ferricyanide
corresponds to the NADH:Fe(CN)6
3) oxidoreductase activity (100% corresponds to 1494 nmol K3Fe(CN)6
3) reduced min)1 mg protein)1); CII + III corresponds to the
succinate:cytochrome c oxidoreductase activity (100% corresponds to 25 nmol cytochrome c reduced min)1 mg protein)1); CIV corresponds to the cytochrome c
oxidase activity (100% corresponds to 310 nmol cytochrome c oxidized min)1 mg protein)1). Asterisks indicate statistically significantly differences between LP1
and T1 or LP2 and T2 using Student’s t test, with a significance threshold of 0.05. The results are means  SD of 3–6 independent experiments.
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activity of complex I (rotenone-sensitive NADH:duroqui-
none) was observed in both LP1 and LP2 compared to T1 and
T2 (10–20% activity remaining), even though the activity of
this latter strain is lower than that of T1. In contrast, the
NADH:ferricyanide oxidoreductase activity was only
reduced by approximately 40% in LP1 and LP2, but the dif-
ference was still significant (P < 0.05). In plant membrane
extracts, this activity reflects not only the NADH dehydro-
genase activity of the peripheral arm of complex I, but also
that of other cellular NADH dehydrogenases (Quiles et al.,
1996). As a mutant completely deprived of the NADH dehy-
drogenase activity of complex I retained approximately 10%
of the total NADH:ferricyanide oxidoreductase activity
(dum17; Cardol et al., 2002), we conclude that the activity of
the peripheral arm is mildly reduced in LP1 and LP2. No
significant modification of complex IV activity was noticed.
However, a significant increase (P < 0.05) in complex II + III
activity was seen.
To analyze the effect of the Leu ﬁ Pro substitution on
complex I assembly, mitochondria from T1 and LP1 strains
lacking cell walls were then solubilized using n-dodecyl-
b-D-maltoside and used for BN–PAGE (Figure 3). Various
amounts of mitochondrial extracts of both strains were
loaded. Complex I was detected by Coomassie blue stain-
ing (Figure 3a), which detects the respiratory complexes,
and NADH/nitroblue tetrazolium staining (Figure 3b), which
reveals the NADH dehydrogenase activity of complex I.
Complex I was detected at 950 kDa in both LP1 and T1,
demonstrating that the Leu ﬁ Pro mutation did not
prevent assembly of complex I (Figure 3a,b). Coomassie
blue staining of complex I was similar for T1 and LP1 for
each loading. This means that the amount of complex I
assembled in LP1 does not differ compared to T1. This was
confirmed by analyzing the steady-state level of the 49 kDa
subunit, a nuclear-encoded subunit of the peripheral arm
of complex I (Figure 3e). In contrast, NADH/nitroblue
tetrazolium staining showed that LP1 complex I displays
lower NADH dehydrogenase activity (Figure 3b), as already
noted (Figure 2, NADH:ferricyanide oxidoreductase activ-
ity). Dimeric complex V was detected at 1700 kDa, and
Figure 3 shows that there was no modification of its
amount (Figure 3a) or activity (Figure 3c). Similar conclu-
sions were drawn for complex IV (Figure 3a,d). Super-
complex III2 + IV was also detected (Figure 3d), an associ-
ation that is also described in plant mitochondria (Eubel
et al., 2004). The same analyses were performed on mito-
chondria from T2 and LP2 strains lacking cell walls, with
similar results (Figure S1).
Membrane potential is not affected in mitochondria of Leu
ﬁ Pro transformants
Complex I links electron transfer from NADH to ubiquinone
to the pumping of four protons from the matrix into the
inter-membrane space. To determine whether the mem-
brane potential of mitochondrial membranes was affected
by the reduced activity of complex I in LP1 and LP2, mito-
chondria from living cells of all the transformants were
labeled separately using two MitoTracker dyes and
observed under confocal laser microscopy. The first
MitoTracker dye (MitoTracker Orange CMTMRos) is
sequestered in the mitochondria when entering an actively
respiring cell. It is thus dependent on membrane potential.
The second dye (MitoTracker Green FM) is essentially
non-fluorescent in aqueous solutions, only becoming fluo-
rescent once it accumulates in the lipid environment of
mitochondria, regardless of membrane potential. Figure 4
(a) (b) (c)
(d)
(e)
Figure 3. Analysis of mitochondrial complexes
from T1 and LP1.
(a, b) Solubilized mitochondria (20 and 40 lg)
were subjected to BN–PAGE and stained using
Coomassie blue (a) or NADH/nitroblue tetrazo-
lium (b), showing the NADH dehydrogenase
activity of complex I.
(c, d) Solubilized mitochondria from T1 or LP1
(50 lg) were subjected to BN–PAGE and stained
for ATP synthase activity (c) or complex IV
activity (d).
(e) SDS–PAGE of T1 and LP1 mitochondria
(20 lg) probed using antiserum against the
49 kDa subunit of Chlamydomonas complex I.
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illustrates the analysis of T2, LP2, dum22 and dum17.
Mitochondria of the latter mutant lack complex I. There was
no obvious difference in mitochondrial labeling between
LP2 and T2 for either MitoTracker dye (Figure 4a,b). Analy-
sis of the dum17 mutant gave the same results (Figure 4d).
This suggests that respiration is still high enough to allow
sequesteration of MitoTracker Orange inside the mito-
chondria of these strains. In contrast, labeling of the dum22
mitochondria was much weaker with MitoTracker Orange
than with MitoTracker Green, indicating that membrane
potential was affected. This is in agreement with the
severity of the dum22 mutation, which affects both cob and
nd4. The activity of complex I and also that of the cyto-
chrome pathway of respiration (complex III and com-
plex IV) are lost in this strain, and therefore the proton
gradient and the membrane potential are severely per-
turbed. The same analyses were performed on T1, LP1 and
dum11 and gave the same results (Figure S2): no differen-
tial labeling of mitochondria from T1 and LP1 was observed
and mitochondria from the dum11 mutant were only very
weakly labeled with MitoTracker Orange.
Confocal analyses also revealed that the organization of
Chlamydomonas mitochondria may vary: from a thick
tubular network (T2 and LP2) to highly branched expansions
(dum22), thick corded bodies (dum17 and LP1) or small
lumps scattered throughout the cytoplasm (T1) (Figure S2).
These forms may correspond to cells at various stage of their
life cycle (Ehara et al., 1995). Autofluorescence of the
chlorophyll was also observed, showing a single horse-
shoe-shaped chloroplast in the cell. Merging of the two
images illustrates the close connection between mitochon-
dria and chloroplasts.
The Leu ﬁ Pro substitution has an effect on dark
respiration and growth rate in vivo but no effect on H2O2
production
Oxygen consumption in the dark in medium containing
acetate as the organic carbon source was significantly
reduced (by approximately 40%) in both LP1 and LP2
(Table 1 and Table S3). In addition, respiration appears to be
less sensitive to rotenone (a specific inhibitor of complex I)
in these two transformants (38% for LP1 versus 54% for T1,
and 29% for LP2 versus 44% for T2), suggesting that the
contribution of this complex to respiration was decreased.
This led to a significant decrease (P < 0.05) in the growth
rate under heterotrophic conditions (dark + acetate) (Ta-
ble 1) in LP1 and LP2.
Complex I and complex III are the two major sites of
production of reactive oxygen species (ROS) in the respira-
tory chain and also in the cell (Balaban et al., 2005; Hirst,
2010). The H2O2 level was thus measured in whole cells after
heterotrophic growth. The level of H2O2 was slightly higher
in LP1 and LP2 than in T1 and T2, but the difference was not
significant (Table 1).
Figure 4. Mitochondria stained with MitoTracker dyes and visualized using
confocal microscopy.
Visualisation of mitochondria from (a) T2, (b) LP2, (c) dum22 and (d) dum17
strains stained with MitoTracker Orange and Green FM, and of chloroplasts by
autofluorescence of chlorophyll (red). The merged images show the locali-
zation of chloroplasts and mitochondria in the same cell. Scale bar = 5 lm.
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DISCUSSION
In this study, two independent transformants (LP1 and LP2)
with a Leu ﬁ Pro substitution in the ND4 subunit of com-
plex I were isolated after biolistic transformation of the
mitochondrial genome of Chlamydomonas. LP1 was
isolated from 300 transformants from the dum11 recipient
strain. Compared to previous results, in which three mito-
chondrial transformants with a short deletion in the 5¢ end of
nd4 were isolated among 90 transformants analyzed (Rem-
acle et al., 2006), this frequency is rather low. This discrep-
ancy is difficult to explain given that the same recipient
strain (dum11) was used in both cases, and that the position
of the two nd4 mutations compared to the dum11 deletion is
roughly the same. The only parameter that differed was the
size of the region flanking the mutation: the fragment of
mitochondrial DNA in the pND4-LP plasmid extended to the
nd5 gene, but the mitochondrial fragment of the pLongD
plasmid used in the previous study extended to the cox1
gene, i.e. it is 1.5 kb longer (Remacle et al., 2006). The longer
fragment is more favorable for integration of the mutation
site by homologous recombination, as it has been shown
that the ratio of flanking homology to insert size is a critical
parameter for transformation frequency and integration of
mutations in chloroplasts of Chlamydomonas and tobacco
(Nicotiana tabacum) (Staub and Maliga, 1992; Dauvillee
et al., 2004) and bacteria (Simpson et al., 2007). In support of
this, a previous study utilizing another plasmid with a
shorter fragment of mitochondrial DNA (extending to the 3¢
end of nd5) for integration of the short deletion in the 5¢ end
of nd4 resulted in recovery of only one heteroplasmic
transformant bearing the mutation (Remacle et al., 2006). In
addition, it is possible that some transformants with the Leu
ﬁ Pro substitution escaped detection because digestion of
the PCR product failed.
Nevertheless, the frequency of complex I transformants
recovered after transformation is low in both studies. As
shown below, complex I mutations are responsible for
lower fitness, especially under heterotrophic conditions. As
transformant selection occurs under these conditions, it is
probable that some copies of the mitochondrial genome in
which the mutation is integrated are lost as a result of gene
conversion and recombination during the segregation pro-
cess, as has been demonstrated in tobacco chloroplasts
(Khakhlova and Bock, 2006).
When the dum22 strain was used as recipient strain, the
situation is even worse, as only two transformants (T2 and
LP2) were recovered for the transformation experiment
compared to the 300 ones using dum11. The dum22 mutant
is a very fragile strain that is extremely dependent on light for
growth as it does not produce any ATP by the oxidative
phosphorylation process. It is thus probable that a high
number of cells die during the selection process before
integration of foreign DNA. In addition, as the deletion
extends up to the middle of the nd4 gene, the ratio of flanking
sequence to insert size is lower than when using the dum11
strain in which cob is partially deleted. Nevertheless, the two
wild-type transformants (T1 and T2) and the mutants (LP1 and
LP2) present basically the same characteristics except that
complex Iactivity (NADH:duroquinone) is higher in T1 than in
T2 and growth under heterotrophic conditions is faster for T2
than for T1. These differences may arise from the genetic
background of the strains: the dum11 strain belongs to the
genus reinhardtii whereas the dum22 strain is derived from a
cross between a C. reinhardtii and a C. smithii strain (Rem-
acle et al., 2001b).
The hydrophobic ND4 subunit located at the distal part of
the membrane domain of complex I (Sazanov et al., 2000;
Baranova et al., 2007) is proposed to play a central role in
complex I function by participating in proton translocation
and/or ubiquinone binding (Mathiesen and Hagerhall, 2002;
Zickermann et al., 2009; Efremov et al., 2010; Hunte et al.,
2010). Our results confirm this central role as a single Leu
ﬁ Pro substitution at position 157 of the 6th transmem-
brane segment is responsible for almost complete loss of
complex I activity (NADH:duroquinone oxidoreductase
activity). This leucine may play a role in the binding of
ubiquinone. However, the participation of ND4 (together
with ND5) in the ubiquinone binding pocket is still a matter
of debate, because both subunits are located in the distal
part of the membrane domain, which is distant from the
ubiquinone reduction site mapped near Fe–S cluster N2 in
the hydrophilic peripheral arm in the vicinity of the 49 kDa
and PSST subunits (Darrouzet et al., 1998; Tocilescu et al.,
Table 1 Dark respiration, doubling time and ROS production in T1,
LP1, T2 and LP2
T1 LP1 T2 LP2
Dark respirationa
Total 13  1.0 8  1.0* 12  0.3 7  1.0*
With 100 lM
rotenone
6  2.0 5  1.0 8  0.4 5  2.0
Doubling time under
heterotrophic
growth conditionsb
47  1.0 67  7.0* 30  4.0 59  15.0*
ROS quantification
Heterotrophic
growthc
100  22.0 127  21.0 100  11.0 114  27.0
aDark respiration (nmol O2 min
)1 cells density)1 measured at 750 nm
 SD) was measured in the absence or presence of 100 lM rotenone
(means of 3–6 independent experiments).
bDoubling times were measured under heterotrophic conditions and
are expressed in hours (mean  SD of three independent experi-
ments).
cROS quantification were measured on heterotrophic cultures and is
expressed as a percentage of T1 or T2 (mean  SD of three
experiments).
Asterisks indicate statistically significantly differences between LP1
and T1 or LP2 and T2 using Student’s t test, with a statistical
significance threshold of 0.05.
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2007; Zickermann et al., 2009). As far as proton pumping is
concerned, a conserved glutamic acid located at position 144
of the 5th transmembrane segment of the corresponding
subunit (NUOM) of Escherichia coli complex I (position 124
in Chlamydomonas ND4) is proposed to play a role in proton
transport across the inner mitochondrial membrane (Torres-
Bacete et al., 2007). However, the leucine analyzed here is a
hydrophobic residue and is thus not able to participate in
proton translocation as transport across the membrane is
facilitated by acidic or basic transmembrane amino acids
(Zickermann et al., 2009). In vitro dissection of the proton
pump of complex I in the fungus Yarrowia lypolytica
recently showed that the membrane domain of complex I
comprises two functionally distinct pump modules, each
one pumping two protons. One is close to the hydrophilic
arm and the other is located at the distal part of the
membrane domain comprising ND4 and ND5 (Dro¨se et al.,
2011). Therefore, we cannot completely rule out the possi-
bility that proton pumping is affected in Leu ﬁ Pro
transformants, but this would require more refined analyses
on highly purified complex I. We did not observe any
differences in sequesteration of MitoTracker dyes between
living cells of Leu ﬁ Pro and wild-type transformants by
confocal analyses. This suggests that proton pumping of
complex I and the membrane potential of the inner mito-
chondrial membrane are not severely affected. However, we
did not observe any differences with the dum17 mutant
either. This suggests that the method we used is not
sensitive enough to detect any change in membrane
potential linked to complex I, or that the loss of proton
pump is partially compensated for in vivo, for example by
increased complex II + III activity. In contrast, when the
cytochrome pathway of respiration (dum11) or the cyto-
chrome pathway and complex I (dum22) are lost, differ-
ences in labeling between MitoTracker Orange and
MitoTracker Green were observed. In these cases, eight
and all ten protons (per O2 reduced), respectively, are not
pumped into the inter-membrane space.
As expected because the ND4 subunit is located in the
hydrophobic part of complex I, the NADH dehydrogenase
activity of the peripheral hydrophilic arm is only mildly
reduced,asalreadynotedforothersubstitutions in theNUOM
subunit of E. coli complex I (Torres-Bacete et al., 2007).
The ND4 subunit is also affected in other mitochondrial
mutants of Chlamydomonas, but in these cases, the nd4
gene is truncated and the ND4 subunit is missing. In
homoplasmic ND4-deficient cells, assembly of complex I is
compromised, as a 700 kDa membrane-associated sub-
complex is detected. This sub-complex completely lacks
NADH:duroquinone activity and displays very low NADH
dehydrogenase activity (Cardol et al., 2002; Remacle et al.,
2006). The sub-complex is less tightly bound to the mem-
brane than the wild-type enzyme, and mainly comprises
subunits belonging to the matrix-exposed arm (Cardol et al.,
2008). In maize (Zea mays), the NCS2 ND4-deficient mutant,
also displays a partially assembled complex I that is loosely
attached to the mitochondrial inner membrane (Karpova
and Newton, 1999). The NCS2 mutant is in the heteroplasmic
state, and is characterized by pale green leaf striping, sectors
of aborted kernels on the ears and a reduction of overall
plant growth (Marienfeld and Newton, 1994). The pheno-
types associated with loss of ND4 in both Chlamydomonas
and maize are thus rather similar from the biochemical point
of view. However, plants appear to be more severely
affected than Chlamydomonas at the physiological level
and do not generally tolerate homoplasmic mitochondrial
mutations, probably because of their multicellular and
complex tissue organization resulting in specific energy
demands.
The in vitro effects observed for the Leu ﬁ Pro substi-
tution are correlated with a clear phenotype in vivo in
Chlamydomonas as dark respiration and growth rates are
impaired when the mutation is present in the homoplasmic
state. The reduction of growth rate displayed by LP1 and LP2
under heterotrophic conditions indicates the importance of
complex I in respiratory metabolism, as observed previ-
ously (Remacle et al., 2001a, 2006; Cardol et al., 2002).
Oxidation of NADH produced by the Krebs cycle must occur
through the activity of type II (non-pumping) NADH
dehydrogenases such as Nda1, which is located at the inner
face of the inner mitochondrial membrane (R. Lecler and C.
Remacle, unpublished data, Genetics of Microorganisms,
Department of Life Sciences, University of Lie`ge, Belgium),
leading to a decrease in oxygen consumption. In the light,
complex I mutations have less impact as ATP synthesis can
rely on photosynthesis (Cardol et al., 2003).
However, type II NADH dehydrogenases are not found in
human mitochondria. Complex I mutations are thus much
more damaging, which could explain why they are usually
found in a heteroplasmic state. Pulkes et al. (2003) did not
observe any respiratory chain defect in muscle tissue of a
patient exhibiting the Leu ﬁ Pro substitution. They
suggested that the mitochondria that were analyzed could
be from muscle that contained a low proportion of mutant
mitochondrial DNA or that an unidentified nuclear gene
mutation could be responsible for the phenotype (Pulkes
et al., 2003). Our results provide evidence that indirectly
supports the first hypothesis, as the proportion of mutated
versus wild-type copies of the mitochondrial genome may
vary greatly between tissues (Venegas et al., 2011). How-
ever, the Leu ﬁ Pro substitution in Chlamydomonas may
not faithfully mimic the human one because of the presence
of a non-conserved amino acid at position 159 in humans
(proline in humans and valine in Chlamydomonas).
Even though ROS production (in our case H2O2) was
slightly higher in LP1 and LP2, the difference was not
significant. In complex I, molecular oxygen can be reduced
by the flavin moiety to form the ROS superoxide and
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hydrogen peroxide (H2O2) (Hirst, 2010). The absence of
significant ROS modification may be explained by the only
moderate decrease in activity of the peripheral arm
(NADH:ferricyanide activity) harboring the flavine co-factor
in LP1 and LP2.
The unicellular green alga Chlamydomonas thus repre-
sents a very useful model to reconstruct human mitochon-
drial complex I mutations in the homoplasmic state.
Evidence for the pathogenicity of a given mutation can be
obtained experimentally because respiratory enzyme activ-
ities are readily measured on membrane fractions, mito-
chondria are easily purified, and complex I is conveniently
detected by BN–PAGE. In vivo parameters such as respira-
tion, growth and ROS production are also easily measured.
In addition, confocal microscopy allows the analysis of
mitochondria in vivo, which could be useful for the detection
of morphological changes that may arise following respira-
tory disorders (Ruiters et al., 1991; Poot et al., 1996),
although in our case, confocal studies were used for
evaluating differences in membrane potential.
Compared to prokaryotic complex I, which only contains
14 subunits and is located in the plasma membrane,
Chlamydomonas complex I better reflects the complexity
of eukaryotes as the enzyme is confined to mitochondria and
contains almost as many subunits as human complex I (42
versus 45; Cardol et al., 2004). These subunits are highly
conserved, as all 45 mammalian subunits except two
possess homologs in other eukaryotic lineages (Cardol,
2011). This implies that results obtained in Chlamydomonas
can be extrapolated to humans with confidence as far as
fundamental aspects linked to complex I are concerned.
EXPERIMENTAL PROCEDURES
Strains and growth conditions
The strains used in this study are derived from the wild-type 137c
strain of C. reinhardtii. The following mitochondrial mutants were
used: (i) dum11, which exhibits a 1.2 kb deletion extending be-
yond codon 147 of cob that is responsible for loss of complex III
activity (Remacle et al., 2006), (ii) dum22, which has a deletion
extending beyond the 3¢ end of the nd4 sequence (Remacle et al.,
2001b), and (iii) dum17, which contains a frameshift in mito-
chondrial nd6 and lacks complex I activity and assembly (Cardol
et al., 2002). Cells were routinely grown at 25C under heterotro-
phic conditions (dark + acetate) or mixotrophic conditions
(light + acetate). The light intensity used was 50 lE m)2 sec)1, and
the medium used contained Tris-acetate phosphate (TAP) (Harris,
1989).
PCR and DNA analyses
Chlamydomonas reinhardtii total nucleic acids were prepared as
described by Newman et al. (1990). PCR fragments were amplified
either from total DNA or directly on Chlamydomonas colonies as
described by Remacle et al. (2006), using KAPA HiFi HotStart DNA
polymerase (KapaBiosystems, http://www.sopachem.com) or Taq
polymerase(http://www.promega.com).
The primers used for amplification of the nd4 450 bp PCR
fragment were nd4-F (5¢-AGTTGGAGCAGCTACGTGA-3¢) and nd4-
R (5¢-ATCGATGGCGTAGCTCTAAGC-3¢). Digoxigenin-labeled PCR
probes for cob and nd2 were amplified using cob-F (5¢-CC
GCGTACCGTAAGTGTAAA-3¢) and cob-R (5¢-CCGGTCACGGTAT
TATCATG-3¢), or nd2-F (5¢-ATGATTGAGCTTGACTTGTGT-3¢) and
nd2-R (5¢-ACCGGTTCGCTGATACATGG-3¢), as recommended by the
supplier of the kit used for labeling PCR products with digoxigenin
(Roche Molecular Biology, http://www.roche.com).
Sequencing was performed directly on amplified products by
BeckmanCoulterGenomics (http://www.beckmangenomics.com).
The primers cob-F (above) and cob-2R (5¢-GGAACGGTGGTTCTC-
TAGCTGG-3¢), nd4-2F (5¢-GGTAGGCTACCAAATGAGTG-3¢) and
nd4-2R (5¢-ACAGCGTTCGATTTTAGCAG-3¢), or nd5-F (5¢-CATTGA-
AACAAGCACGCAG-3¢) and nd5-R (5¢-CATGATAATACCGTGACC-
GG-3¢) were used to amplify and sequence the cob, nd4 and nd5
genes, respectively.
Southern blots were performed as described by Remacle et al.
(2006).
DNA construct and Chlamydomonas transformation
The plasmid used in this work was constructed by ATG:biosyn-
thetics (https://www.atg-biosynthetics.com) and named pND4-LP. It
is 7753 bp long and comprises the chloramphenicol resistance gene
and the first 4966 bp of the Chlamydomonas mitochondrial gen-
ome, including cob, nd4 and nd5. The nd4 gene has a TTG ﬁ CCA
mutation involving a leucine to proline substitution at codon 157.
The proline codon CCA was chosen as described by Boer and Gray
(1988). For transformation experiments, the plasmid was used at a
concentration of 1 lg ll)1 and linearized using BglI. The transfor-
mation procedure was performed as described by Remacle et al.
(2006).
Enzyme activities
Enzyme activity analyses were performed on membrane fractions
prepared as described by Remacle et al. (2001a). NADH:ferricyanide
oxidoreductase, complex I (rotenone-sensitive NADH:duroquinone
oxidoreductase), complex II + III (succinate:cytochrome c oxidore-
ductase) and complex IV (cytochrome c oxidase) activities were
measured as described previously (Remacle et al., 2001a; Cardol
et al., 2002).
Protein complex analysis
Protein complex analyses were performed on purified mitochondria
and mitochondrial membranes. Mitochondria were isolated from
strains lacking cell walls as described previously (Cardol et al.,
2002). The protein content was determined as described by Brad-
ford (1976).
To perform BN–PAGE analyses, protein complexes from purified
mitochondria were solubilized in the presence of 1.5% w/v
n-dodecyl-b-D-maltoside, 375 mM 6-aminohexanoic acid, 250 mM
EDTA and 25 mM Bis/Tris, pH 7.0. Solubilized protein complexes
were centrifuged for 20 min at 15 000 g at 4C to remove insoluble
material. Coomassie blue G (1% w/v) was then added to the
supernatant prior to separation by electrophoresis on a 4–12%
acrylamide gradient BN gel (Schagger and von Jagow, 1991).
Coomassie blue staining and in-gel detection of NADH dehydro-
genase, ATP synthase or complex IV activities were performed as
described previously (Remacle et al., 2010). SDS–PAGE was per-
formed as described by Remacle et al. (2010). A polyclonal antibody
directed against the Chlamydomonas 49 kDa subunit was used at a
dilution of 1:3000 for Western blotting analyses.
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Dark respiration
Measurements of dark respiration were obtained using a Clark
electrode (Hansatech Instruments, http://www.hansatech-
instruments.com) as described by Duby and Matagne (1999).
Rotenone dissolved in dimethyl sulfoxide (DMSO, 15 mM) was used
at a final concentration of 100 lM.
Staining for accumulation of H2O2 using
3,3-diaminobenzidine
Equal amounts of cells (normalized at 750 nm), grown under
heterotrophic conditions for 10 days, were placed on filter discs and
moistened with medium containing 5 mM 3,3-diaminobenzidine.
Filter discs were exposed to moderate light (50 lE m)2 sec)1) for
40 min. Following 3,3-diaminobenzidine treatment, pigments were
bleached from the cells using methanol to compare levels of the
reddish-brown polymerization product of 3,3-diaminobenzidine due
to interaction with H2O2. Staining intensities were assessed semi-
quantitatively by densitometry, and are shown as percentage of the
equivalent wild-type sample, which was normalized to 100% (For-
ster et al., 2005; Remacle et al., 2010).
MitoTracker staining and confocal microscopy
1 · 108 cells were washed once with TAP medium, and then
incubated in the dark for 30 min in TAP medium to which 1 lM
of MitoTracker Orange CMTMRos or Green FM (Molecular
Probes, www.invitrogen.com/site/us/en/home/brands/Molecular-
Probes.html) was added. Stained cells were washed with TAP
medium, and living cells were directly observed on Superfrost
plus slides (Menzel-Glaser, http://www.menzel.de/). For live-cell
imaging, a Leica TCS SP5-II AOBS inverted confocal laser
microscope (Leica Microsystems, http://www.leica.com/) and a
63 · 1.2 numerical aperture Plan-Apo water-immersion objective
were used to collect images at 1024 · 1024 pixel resolution.
MitoTracker Orange was detected at an excitation wavelength of
543 nm, and the fluorescence emission was dispersed and
recorded at 550–590 nm. MitoTracker Green was detected at an
excitation wavelength of 490 nm, and the fluorescence emission
was dispersed and recorded at 495–570 nm. The autofluores-
cence of chlorophyll was detected at an excitation wavelength of
488 nm, and the fluorescence emission was dispersed and
recorded at 650–750 nm. The diameter of the pinhole was set to
an Airy unit, and we ensured that the maximal fluorescence
signal did not saturate the photo-multiplier tubes. A series
of optical sections was taken to analyze the spatial distribution of
mitochondria, recorded with a Z-step of 0.5 lm.
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Supplemental Table 1: Respiratory enzyme activities of T1, LP1, T2 and LP2 strains 
    
  
 
 
Supplemental Table 2: P values of respiratory enzyme activities of T1, LP1, T2 and LP2 
strains 
     
 
 
 T1 LP1 T2 LP2 
Specific activities on membrane fractions  
Complex I 
a 
83±4 
 
5±3* 
 
34±4 
 
7±2* 
NADH:Fe(CN)6
3−
oxidoreductase
b
 1494±361  910±145*  1652±398  
 
913±117*  
 
Complex II+III
c
 25±1 46±5* 30±5 47±2* 
 
Complex IV
d
 
 
310±63 
 
368±13 
 
324±39 
 
312±32 
     
 T1 LP1 T2 LP2 
Student’s t test P values (statistical significance threshold = 0.05)  
Complex I        6.80.10
-6
 3.53.10
-4
 
NADH:Fe(CN)6
3−
oxidoreductase 0.030 0.00049 
Complex II+III
c
 0.028 6.80.10
-6
 
Complex IV   0.33  0.75 
 Supplemental Table 3: P values of dark respiration, doubling time and H2O2 production 
experiments in T1, LP1, T2 and LP2 strains 
 T1 LP1 T2 LP2 
Student’s t test P values (statistical significance threshold = 0.05)  
Dark respiration   
Total
a
 0.0024 0.012 
+ rotenone 100 μMa 
 
0.57 0.057 
Doubling time    
Heterotrophic growth conditions
b
 0.0082 0.040 
ROS Quantification    
Heterotrophic growth
c
  0.26 
 
0.47 
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Supplemental data legends 
Supplemental Figure 1: Analysis of mitochondrial complexes from T2 and LP2 
 (A) 20 and 40 µg of solubilized mitochondria of T2 and LP2 were loaded on a BN-
PAGE and stained with NADH/NBT, revealing the NADH dehydrogenase activity of 
complex I. (B) 50 µg of solubilized mitochondria of T2 and LP2 were loaded on a 
BN-PAGE and stained with DAB revealing complex IV activity. (C) SDS-PAGE of 
T2 and LP2 mitochondria (20 µg) was blotted and probed with an antiserum against 
the 49 kDa subunit of Chlamydomonas complex I.  
 
Supplemental Figure 2: Mitochondria stained with MitoTracker dyes and 
visualized using confocal microscopy 
Visualisation of mitochondria from (A) T1, (B) LP1, (C) dum11 strains stained with 
MitoTracker Orange and Green FM, and of chloroplast using autofluorescence of 
chlorophyll (in Red). The white line corresponds to 5 µm. The superposition of the 
two images shows the localization of chloroplast and mitochondria in the same cell.  
 
Supplemental Table 1: Respiratory enzyme activities of T1, LP1, T2 and LP2 
strains 
Specific activities (±SD from three to six experiments) were measured in membrane 
fractions of T1, LP1, T2, LP2: 
a
Rotenone-sensitive complex I activity (nmol of 
NADH oxidized min
−1
 mg protein
−1
), 
b
NADH:ferricyanide oxidoreductase activity 
[nmol of K3Fe(CN)6
3−
 reduced min
−1
 mg protein
−1
], 
c
succinate:cytochrome c 
oxidoreductase activity (nmol of cytochrome c reduced min
−1
 mg protein
−1
), and 
d
cytochrome c oxidase activity (nmol of cytochrome c oxidized min
−1
 mg protein
−1
). 
Asterisks indicate statistically significantly differences between LP1 and T1 or LP2 
and T2 using Student’s t test with a statistical significance threshold of 0.05. 
 
 2 
Supplemental Table 2: P values of respiratory enzyme activities of T1, LP1, T2 
and LP2 strains 
P values (Student’s t test) obtained comparing activities of T1/LP1 and T2/LP2. The 
statistical significance threshold chosen was 0.05, each value obtained under 0.05 
shows a statistically significantly difference between the two samples.  
 
Supplemental Table 3: P values of dark respiration, doubling time and H2O2 
production experiments in T1, LP1, T2 and LP2 strains 
P values (Student’s t test) comparing results from in vivo assays of T1/LP1 and 
T2/LP2. The statistical significance threshold chosen was 0.05, each value obtained 
under 0.05 shows a statistically significantly difference between the two samples.  
 
 
